SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant /X/
Filed by a party other than the Registrant / /

Check the appropriate box:
/ / Preliminary Proxy Statement
/ / Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
/X/ Definitive Proxy Statement
/ / Definitive Additional Materials
/ / Soliciting Material Pursuant to Section 240.14a-12

The Clorox Company
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)

- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

/X/ No fee required.

/ / Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11.

(1) Title of each class of securities to which transaction applies:

------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:

------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):

------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:

------------------------------------------------------------------------
(5) Total fee paid:

------------------------------------------------------------------------

/ / Fee paid previously with preliminary materials.

/ / Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:

------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:

------------------------------------------------------------------------
(3) Filing Party:

------------------------------------------------------------------------
(4) Date Filed:

------------------------------------------------------------------------

- --------------------------------------------------------------------------------

[CLOROX LOGO]

THE CLOROX COMPANY

---------

NOTICE OF 2000 ANNUAL MEETING
PROXY STATEMENT
AND
ANNUAL FINANCIAL STATEMENTS

-------------

ANNUAL MEETING OF
STOCKHOLDERS
NOVEMBER 15, 2000

- --------------------------------------------------------------------------------

[CLOROX LOGO]

THE CLOROX COMPANY
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON NOVEMBER 15, 2000

The Annual Meeting of Stockholders of The Clorox Company, a Delaware corporation
(the "Company"), will be held at 9:00 A.M. on Wednesday, November 15, 2000, at
the offices of the Company, 1221 Broadway, Oakland, California, for the
following purposes:

1. To elect a board of eleven directors to hold office until the next
annual election of directors;

2. To ratify the selection of Deloitte & Touche LLP, certified public
accountants, for the fiscal year ending June 30, 2001; and

3. To transact such other business as may properly come before the meeting
or any adjournment thereof.

The board of directors has fixed the close of business on September 18, 2000 as
the record date for determining the stockholders entitled to notice of, and to
vote at, the meeting and any adjournment thereof. A list of such stockholders
will be available at the time and place of the meeting and, during the ten days
prior to the meeting, at the office of the Secretary of the Company at 1221
Broadway, Oakland, California.

A copy of the Company's Annual Report for the fiscal year ended June 30, 2000 is
included with this mailing.

IT IS IMPORTANT THAT YOUR SHARES BE REPRESENTED AT THIS MEETING. EVEN IF YOU
PLAN TO ATTEND THE MEETING, WE HOPE THAT YOU WILL READ THE ENCLOSED PROXY
STATEMENT AND THE VOTING INSTRUCTIONS ON THE ENCLOSED PROXY CARD, AND THEN VOTE
(1) BY COMPLETING, SIGNING, DATING AND MAILING THE PROXY CARD IN THE ENCLOSED
POSTAGE PRE-PAID ENVELOPE, OR (2) BY CALLING THE TOLL-FREE NUMBER LISTED ON THE
PROXY CARD, OR (3) VIA THE INTERNET AS INDICATED ON THE PROXY CARD. THIS WILL
NOT LIMIT YOUR RIGHT TO ATTEND OR VOTE AT THE MEETING.

BY ORDER OF THE BOARD OF DIRECTORS

[SIGNATURE]

PETER D. BEWLEY,
SENIOR VICE PRESIDENT -- GENERAL
COUNSEL AND SECRETARY

September 29, 2000

THE CLOROX COMPANY
1221 BROADWAY
OAKLAND, CALIFORNIA 94612

PROXY STATEMENT

This proxy statement is furnished in connection with the solicitation of proxies
by the board of directors of The Clorox Company, a Delaware corporation (the
"Company"), for use at the Annual Meeting of Stockholders of the Company, to be
held at 9:00 A.M. on November 15, 2000 at the above offices of the Company (the
"Annual Meeting").

THE PROXY

A stockholder giving the enclosed proxy may revoke it at any time before it is
used by giving written notice of revocation to the Secretary of the Company or
by voting in person at the Annual Meeting.

VOTING AT THE ANNUAL MEETING

All share numbers in this proxy statement give effect to the two-for-one stock
split declared July 20, 1999, effected in the form of a stock dividend paid
August 23, 1999 on all shares of the Company's common stock, $1.00 par value
(the "Common Stock"), outstanding as of the close of business on July 30, 1999.

The only voting securities of the Company are its shares of Common Stock, of
which 235,529,715 shares were outstanding and entitled to vote at the close of
business on September 18, 2000. Only stockholders of record at the close of
business on September 18, 2000 are entitled to vote at the Annual Meeting. The
holders of the Common Stock are entitled to one vote per share on each matter
submitted to a vote of stockholders.

The holders of a majority of the issued and outstanding Common Stock, present in
person or by proxy, will constitute a quorum for the transaction of business at
the Annual Meeting or any adjournment thereof. Abstentions and broker non-votes
are counted as shares that are present and entitled to vote for purposes of
determining the presence of a quorum. Abstentions are not counted as votes cast
on the proposed election of directors, but will have the same legal effect as a
vote against the proposed ratification of the appointment of independent
auditors. Broker non-votes are not counted as votes cast on any matter to which
they relate.

This proxy statement and the accompanying proxy are first being sent or given to
stockholders on or about September 29, 2000.

PROPOSAL NO. 1:
NOMINEES FOR ELECTION AS DIRECTORS

At the Annual Meeting, eleven persons will be elected as members of the board of
directors, each for a one-year term. The Nominating Committee of the board of
directors has nominated the eleven persons listed below for election at the
Annual Meeting. All of such nominees were elected at the Company's Annual
Meeting of Stockholders held on November 17, 1999, except Mr. Christoph Henkel.

The proxies given to the proxyholders will be voted or not voted as directed
and, if no direction is given, will be voted FOR these eleven nominees. The
board of directors knows of no reason why any of these nominees should be unable
or unwilling to serve. However, if for any reason any nominee should be unable
or unwilling to serve, the proxies will be voted for the election of such other
person to the office of director as the board of directors may nominate in the
place of such nominee. Directors will be elected by a plurality of the shares
represented and voting at the meeting.

Certain information with respect to each nominee appears on the following pages,
including age, period or periods served as a director, position (if any) with
the Company, business experience during at least the past five years and
directorships of other publicly-owned corporations.

------------------------------------------------------------------------------------
NAME, PRINCIPAL OCCUPATION DIRECTOR
AND OTHER INFORMATION SINCE
------------------------------------------------------------------------------------

DANIEL BOGGAN, JR. Senior Vice President, the National
Collegiate Athletic Association. 1990

Mr. Boggan became Senior Vice President of the National
Collegiate Athletic Association in 1996, after having been
Group Executive Director for Education Services for the
National Collegiate Athletic Association since November
1994. Previously, he had been Vice Chancellor for business
and administrative services at the University of
California at Berkeley since 1986. Prior to that, he served
several cities and two counties as a senior manager. Mr.
Boggan is a director of Payless Shoesource, Inc. and serves [PHOTO]
on various local boards. Age: 54.

------------------------------------------------------------------------------------

ELAINE L. CHAO Distinguished Fellow, The Heritage
Foundation. 1999

Ms. Chao is a Distinguished Fellow at The Heritage
Foundation (tax-exempt public policy institute) and Chairman
of the Asian Studies Center Advisory Council. Prior to that,
Ms. Chao was President and Chief Executive Officer of United
Way of America (non-profit charitable organization) from
1992 to 1996. Previously, she was also Director
of the Peace Corps (world's largest volunteer organization)
and Deputy Secretary of the U.S. Department of
Transportation. Ms. Chao is a director of Dole Food Company, [PHOTO]
Inc., Northwest Airlines, Inc., and HCA -- The Health Care
Co. Age: 47.

------------------------------------------------------------------------------------

TULLY M. FRIEDMAN Chairman and Chief Executive Officer,
Friedman, Fleischer & Lowe LLC. 1997

Mr. Friedman is the Chairman and Chief Executive Officer of
Friedman, Fleischer & Lowe LLC (private investment firm).
Prior to that, Mr. Friedman was a founding partner of
Hellman & Friedman (private investment firm) and a managing
director and general partner of Salomon Brothers, Inc. He is
a director of Levi Strauss & Co., Mattel,
Inc., McKesson HBOC, Inc., Archimedes Technology Group, and
Brand Farm. He is also a Trustee of the American Enterprise [PHOTO]
Institute. Age: 58.

------------------------------------------------------------------------------------

CHRISTOPH HENKEL Vice-Chairman of the Shareholders' Commit-
tee, Henkel KGaA.

Mr. Henkel is a Vice-Chairman of the Shareholders' Committee
of Henkel KGaA, Duesseldorf, Germany (manufacturer of
household products and chemicals) and co-chairman of
privately held Cineville Inc. (Los Angeles-based film
production company). He is currently a
director of Head Sports AG and a general partner of Dunton
LLC and Page One LLC, both real estate development firms.
His business experience includes general management
positions at Interpublic Company, Nestle S.A. and Henkel [PHOTO]
KGaA. He is a member of the Henkel family, which controls
Henkel KGaA, and is nominated pursu-
ant to an understanding between the Company and Henkel KGaA
(see Certain Relationships and Transactions, page 9 below).
Age: 42.

------------------------------------------------------------------------------------

JUERGEN MANCHOT Vice-Chairman of the Shareholders' Commit-
tee, Henkel KGaA. 1989

Dr. Manchot is a Vice-Chairman of the Shareholders'
Committee of Henkel KGaA, Duesseldorf, Germany (manufacturer
of household products and chemicals). He is a member of the
Henkel family, which controls Henkel KGaA, and is nominated
pursuant to an understanding between the Company and Henkel
KGaA (see Certain Relation-
ships and Transactions, page 9 below). Age: 63. [PHOTO]

------------------------------------------------------------------------------------

ROBERT W. MATSCHULLAT Former Vice Chairman and Chief
Financial Officer of The Seagram Company Ltd. 1999

Mr. Matschullat was the Vice Chairman and Chief Financial
Officer of The Seagram Company Ltd. (global company engaging
in two business segments: entertainment and spirits and
wine) until his retirement in June 2000. Prior to joining
The Seagram Company Ltd. in 1995, Mr. Matschullat served as
head of worldwide banking for Morgan Stanley
& Co. Incorporated, and was one of six management members of
the Morgan Stanley Group board of directors. He is a [PHOTO]
director of LivePerson, Inc. Age: 52.

------------------------------------------------------------------------------------

DEAN O. MORTON Retired Executive Vice President and Chief
Operating Officer, Hewlett-Packard Company. 1991

Mr. Morton was the Executive Vice President, Chief Operating
Officer and a director of Hewlett-Packard Company
(manufacturer of computer systems and test and measurement
instruments) until his retirement in 1992. Mr. Morton is a
director of ALZA Corp., BEA Systems, Inc., Cepheid,
KLA-Tencor Corporation, and Pharsight Cor-
poration. He is a trustee of the State Street Research group
of mutual funds, and a director of State Street Research
Portfolios, Inc. and the Metropolitan Series Fund, Inc. Age: [PHOTO]
68.

------------------------------------------------------------------------------------

KLAUS MORWIND Executive Vice President, Personally Liable
Associate, and Member of Management Board, Henkel KGaA. 1995

Dr. Morwind is Executive Vice President, Personally Liable
Associate and a member of the Management Board of Henkel
KGaA, Duesseldorf, Germany (manufacturer of household
products and chemicals). He joined Henkel KGaA in 1969 and
held several management positions before assuming his
current responsibility. Dr. Morwind is
nominated pursuant to an understanding between the Company
and Henkel KGaA (see Certain Relationships and Transactions, [PHOTO]
page 9 below). Age: 57.

------------------------------------------------------------------------------------

LARY R. SCOTT Executive Vice President, Arkansas Best
Corporation. 1989

Mr. Scott was elected as Executive Vice President of
Arkansas Best Corporation (holding company with a
multi-industry composition) in January 1996. Previously, he
had been Chairman and Chief Executive Officer of WorldWay
Corporation from May 1993 until January 1996. Prior to that,
Mr. Scott was President and Chief Executive Officer of
Consolidated Freightways, Inc. (worldwide transportation
company). Age: 64. [PHOTO]

------------------------------------------------------------------------------------

G. CRAIG SULLIVAN Chairman of the Board and Chief Executive
Officer of the Company. 1992

Mr. Sullivan has been Chairman of the Board and Chief
Executive Officer of the Company since July 1, 1992.
Previously, he was Vice Chairman and Chief Executive Officer
(May-June, 1992); Group Vice President (1989-1992); Vice
President -- Household Products (1984-1989); and Vice
President -- Food Service Products
(1981-1984). He joined the Company in 1971. Mr. Sullivan is
a director of Levi Strauss & Co. Age: 60. [PHOTO]

------------------------------------------------------------------------------------

C. A. (AL) WOLFE Retired President, U.S. Division, DDB
Needham Worldwide, and President, Al Wolfe Associates, Inc. 1991

Mr. Wolfe is the President of Al Wolfe Associates, Inc., a
marketing and advertising consulting firm. He is the retired
President of the U.S. Division of DDB Needham Worldwide, a
major advertising agency. Previously, Mr. Wolfe had been
Executive Vice President of N.W. Ayer and Executive Vice
President and General Manager of Wells, Rich,
Greene advertising agencies. Age: 68. [PHOTO]

------------------------------------------------------------------------------------

ORGANIZATION OF THE BOARD OF DIRECTORS

The board of directors has established five standing committees: the Executive
Committee, the Finance Committee, the Audit Committee, the Nominating Committee,
and the Employee Benefits and Management Compensation Committee. The Finance,
Audit, Nominating, and Employee Benefits and Management Compensation Committees
consist only of non-management, independent directors.

EXECUTIVE COMMITTEE. The Executive Committee, consisting of directors John W.
Collins, Ursula Fairchild, Friedman, Manchot, Morton, Edward L. Scarff and
Sullivan, is delegated all of the powers of the board of directors except
certain powers reserved by law to the full board. Mr. Collins, Ms. Fairchild and
Mr. Scarff are retiring as directors, and their terms on the board of directors
and all committees thereof will expire at the Annual Meeting. In addition to
being available to meet between regular board meetings on occasions when board
action is required but the convening of a full board is impracticable, the
Executive Committee is authorized to handle special assignments as requested
from time to time by the board. The Executive Committee held no meetings during
fiscal year 2000.

FINANCE COMMITTEE. The Finance Committee consists of directors Boggan, Collins,
Friedman, Manchot, Matschullat, Morton, Morwind and Scarff and, working with the
Company's finance and operating personnel, considers and recommends to the board
major financial policies and actions of the Company. The Finance Committee held
4 meetings during fiscal year 2000.

AUDIT COMMITTEE. The Audit Committee, composed of directors, Matschullat,
Scarff, Scott and Wolfe, is the principal link between the board and the
Company's independent public accountants. The Audit Committee operates in
accordance with a charter (attached as Appendix A) under which it makes
recommendations to the board regarding selection and employment of the Company's
independent auditors and, working with the Company's internal and external
auditors, monitors internal audit and control procedures. The Audit Committee
held 5 meetings during fiscal year 2000.

NOMINATING COMMITTEE. Directors Boggan, Chao, Fairchild, Scarff and Wolfe are
members of the Nominating Committee. The Nominating Committee identifies and
recommends to the board of directors prospective candidates to be considered as
nominees for election to the board. The Nominating Committee will consider board
nominee recommendations by stockholders which are submitted in writing to the
Company's Secretary, together with biographical and business experience
information regarding the nominee and other information that is required by
Article II, Section 11 of the Company's by-laws. The Nominating Committee held 4
meetings during fiscal year 2000.

COMPENSATION COMMITTEE. The Employee Benefits and Management Compensation
Committee (the "Compensation Committee") consists of directors Fairchild,
Friedman, Manchot, Morton and Scott. The Compensation Committee establishes and
monitors the policies under which compensation is paid or awarded to the
Company's executive officers, determines executive compensation, grants stock
options, restricted stock, performance units and other cash or stock awards
under the Company's executive incentive compensation and stock incentive plans,
and reviews pension and other retirement plans for adequacy and compliance with
applicable regulations. The Compensation Committee held 4 meetings during fiscal
year 2000.

The board of directors held nine meetings during fiscal year 2000. All directors
attended at least 75% of the meetings of the board and committees of which they
were members during fiscal year 2000.

Non-management directors received an annual fee of $30,000 for the 2000 fiscal
year. In addition, each non-management director received $1,000 for each board
meeting attended and $1,000 for each committee meeting attended. The chairperson
of each committee received an additional $3,000 annual fee. In addition, each
non-management director is entitled to receive $1,000 per day for any special
assignment requested of any such director by the board. Mr. Collins received a
special assignment fee of $1,000 in January 2000. No other special assignment
fees were paid in fiscal year 2000. Directors may elect to defer all or a part
of this compensation pursuant to the terms of the Company's Independent
Directors' Stock-Based Compensation Plan (the "Directors' Stock-Based
Compensation Plan"). Management directors receive no extra compensation for
their service as directors.

Under the Directors' Stock-Based Compensation Plan, a director may annually
elect to receive all or a portion of her or his annual retainer and meeting fees
in the form of cash, Common Stock, deferred cash or deferred stock units. In
addition, each non-employee director also receives an annual grant of $10,000 of
deferred stock units. Interest accrues on deferred cash amounts at an annual
interest rate equal to Wells Fargo Bank's prime lending rate in effect on
January 1 of each year (8.50% at January 1, 2000). Each deferred stock unit
represents a hypothetical share of Common Stock, and a participant's deferred
stock unit account is increased by Common Stock dividends paid by the Company.
Upon termination of service as a director, the amounts accrued for the director
under the Directors' Stock-Based Compensation Plan are paid out in cash and/or
Common Stock in five annual installments or, at the director's election, in one
lump sum payment of cash and/or Common Stock.

Pursuant to the Company's 1993 Directors' Stock Option Plan (the "Directors
Stock Option Plan"), each non-management director received a grant of stock
options covering 2,000 shares of Common Stock during fiscal year 2000 and will
receive a grant covering 2,000 shares of Common Stock in subsequent fiscal years
for which she or he continues to serve as a director. In addition, Ms. Elaine
Chao received an initial grant of stock options covering 8,000 shares of Common
Stock during fiscal year 2000 in connection with joining the board of directors.
Stock options under the 1993 Directors' Stock Option Plan vest in two equal

installments on each of the first two anniversary dates of the grant date and
have an exercise price equal to the fair market value on the grant date.

Other than the non-management director fees, the deferred stock unit grants
under the Directors' Stock-Based Compensation Plan, and the stock option grants
under the Directors' Stock Option Plan, directors who are not employees of the
Company do not receive any additional form of direct compensation, nor do they
participate in any of the Company's employee benefit plans.

BENEFICIAL OWNERSHIP OF VOTING SECURITIES

The following table shows, as of July 31, 2000, the holdings of Common Stock by
(i) any entity or person known to the Company to be the beneficial owner of more
than 5% of the Common Stock, (ii) each director and each of the six individuals
named in the Summary Compensation Table on page 13 (the "Named Officers"), and
(iii) all directors and executive officers of the Company as a group:

NAME OF AMOUNT AND NATURE OF
BENEFICIAL OWNER(1) BENEFICIAL OWNERSHIP(2) PERCENT OF CLASS(3)
- ------------------- ----------------------- -------------------

HC Investments, Inc.(4) 62,845,700 27%
Anthony W. Biebl 284,744 *
Daniel Boggan, Jr. 11,248 *
Elaine L. Chao 4,000 *
John W. Collins 67,000 *
Ursula Fairchild 36,000 *
Tully M. Friedman 44,600 *
Christoph Henkel(5) 0 *
Gerald E. Johnston 273,268 *
Peter N. Louras(6) 78,729 *
Juergen Manchot 23,000 *
Robert W. Matschullat 6,648 *
Dean O. Morton 27,000 *
Klaus Morwind 16,600 *
Glenn R. Savage 79,424 *
Edward L. Scarff 39,000 *
Lary R. Scott 33,080 *
Frank A. Tataseo 245,313 *
G. Craig Sullivan 1,597,718 *
C. A. (Al) Wolfe 19,000 *
All directors and executive
officers as a group (34
persons)(7) 4,391,783 1.9%

- ---------

NOTES:

* Does not exceed 1% of the outstanding shares.

(1) Correspondence to all executive officers and directors of the Company may be
mailed c/o the Company to 1221 Broadway, Oakland, California 94612. The
address of HC Investments, Inc. is 1105 North Market Street, Suite 1300,
Wilmington, Delaware 19801.

(2) Each beneficial owner listed has sole voting and dispositive power (or
shares such power with her or his spouse) concerning the shares indicated.
These totals include the following number of shares of Common Stock which
such persons have the right to acquire through stock options exercisable
within 60 days of July 31, 2000: Mr. Sullivan -- 1,469,392;
Mr. Johnston -- 242,512; Mr. Louras -- 26,376; Mr. Biebl -- 229,516;
Mr. Tataseo -- 220,868; Mr. Savage -- 69,034; Mr. Boggan -- 9,400;
Ms. Chao -- 4,000; Mr. Friedman -- 11,000; Mr. Matschullat -- 4,000;
Dr. Morwind -- 15,000;

Mr. Wolfe -- 11,000; each of the other non-employee directors -- 19,000; and
all directors and executive officers as a group -- 3,739,989. The numbers in
the table above do not include the following number of shares of Common
Stock which the executive officers have the right to acquire upon the
termination of their service as employees pursuant to vested performance
units granted between April 1996 and June 1998: Mr. Sullivan -- 47,768;
Mr. Louras -- 24,072; and all executive officers as a group -- 63,836. The
numbers in the table above do not include the following numbers of shares of
Common Stock which the executive officers have the right to acquire upon the
termination of their service as employees pursuant to deferred stock units
granted in December 1995 in exchange for the cancellation of certain
restricted stock, and through deferred stock unit dividends thereon:
Mr. Sullivan -- 83,116; Mr. Johnston -- 16,296; Mr. Biebl -- 14,096;
Mr. Tataseo -- 11,942; and all executive officers as a group -- 183,164. The
numbers in the table above do not include the following number of shares of
Common Stock which the non-employee directors have the right to acquire upon
the termination of their service as directors pursuant to deferred stock
units granted under the Directors' Stock-Based Compensation Plan:
Mr. Boggan -- 5,793; Ms. Chao -- 756; Mr. Collins -- 3,877;
Ms. Fairchild -- 15,405; Mr. Friedman -- 3,306; Dr. Manchot -- 4,116;
Mr. Matschullat -- 831; Mr. Morton -- 5,581; Dr. Morwind -- 6,772;
Mr. Scarff -- 32,709; Mr. Scott -- 8,044; and Mr. Wolfe -- 4,165.

(3) On July 31, 2000, there were 235,502,838 shares of Common Stock outstanding.

(4) Indirect wholly-owned U.S. subsidiary of Henkel KGaA of Duesseldorf, Germany
(manufacturer of household products and chemicals).

(5) Mr. Henkel is a first time nominee for director.

(6) Mr. Louras is a former Group Vice President. He ceased to be an executive
officer of the Company on March 1, 2000, and, therefore, his holdings are
not included in the totals for "all directors and executive officers as a
group."

(7) Pursuant to Rule 3b-7 under the Securities Exchange Act of 1934, executive
officers include the Company's CEO, President and all Vice Presidents in
charge of a principal business unit, division or function.

CERTAIN RELATIONSHIPS AND TRANSACTIONS

The Company and Henkel KGaA are parties to a June 1981 letter agreement (as
amended in July 1986 and March 1987, the "Letter Agreement"), relating to
ownership by Henkel KGaA of Common Stock and representation on the Company's
board of directors. The Letter Agreement assures Henkel KGaA of the right to
nominate for election to the board a minimum of two representatives so long as
Henkel KGaA beneficially owns at least 5% of the outstanding shares of Common
Stock. Under the Letter Agreement, Henkel KGaA's maximum permitted ownership of
Common Stock without consultation with the Company is limited to 30%, and Henkel
KGaA has affirmed that it considers its investment in the Company as long-term
and its role in the Company as that of a significant minority stockholder
without an active role in the management of the Company.

The Company and Henkel KGaA have entered into certain joint manufacturing,
marketing and product development arrangements in the United States and
internationally, either directly or through affiliates or joint venture
collaboration. No such arrangements, either individually or in the aggregate,
were material to the Company or Henkel KGaA during fiscal year 2000.

During fiscal year 1995, in connection with joining the Company, Frank A.
Tataseo, Vice President -- Sales of the Company, received a five-year $150,000
mortgage loan without interest from the Company, which he repaid in
November 1999. During fiscal year 2000, in connection with joining the Company,
Wayne L. Delker, Vice President -- Research and Development, received a
five-year $150,000 mortgage loan without interest from the Company, which
remained outstanding at the end of the fiscal year.

EMPLOYEE BENEFITS AND MANAGEMENT COMPENSATION
COMMITTEE REPORT ON EXECUTIVE COMPENSATION

The membership of the Compensation Committee consists entirely of directors who
have never been employees of the Company (see page 6).

COMPENSATION PHILOSOPHY

The Compensation Committee determines executive compensation levels and policies
designed to:

- Motivate each executive toward the achievement of the Company's short and
long-term goals, as reflected in its strategic business plans.

- Be competitive with comparable organizations.

- Ensure that a significant proportion of each executive's total
compensation be at-risk incentive compensation in order to emphasize the
relationship between pay and performance, both Company performance and the
individual's contributions to the Company's results.

- Align the interests of executives with those of stockholders through the
use of equity-based incentive awards.

COMPENSATION OF EXECUTIVE OFFICERS. The key components of the executive
compensation program are base annual salary, annual short-term incentive awards
in the form of stock or cash under the Company's 1996 Executive Incentive
Compensation Plan (the "EIC Plan"), and long-term incentive awards in the form
of stock options and performance units under the Company's 1996 Stock Incentive
Plan (the "Stock Incentive Plan"). The Compensation Committee regularly compares
executive compensation to a compensation comparator group, as described below.
The compensation guidelines are determined by the Compensation Committee based
upon competitive data collected from the compensation comparator group and
internal ranking within the executive officer group. General targeted
competitive levels for base annual salary and annual, at-risk short-term
incentive awards are the 50th percentile of such compensation comparator group.
General targeted competitive levels for at-risk, long-term compensation are also
the 50th percentile with opportunities at the 75th percentile of such
compensation comparator group for

superior financial performance. There is opportunity for the executive officers
to earn more than the targeted levels if the Company's performance exceeds the
measures discussed in this report and less when performance falls below the
targeted levels.

BASE ANNUAL SALARY. Base annual salaries for executive officers are determined
by the following factors: (1) parity to market; (2) the individual's
performance; (3) promotions resulting in increases in responsibility; and
(4) equity in relationship to other executive positions within the Company. With
the assistance of the Company's compensation consulting firm, surveys are
conducted of benchmark positions in the compensation comparator group, 21 other
peer companies, most of which compete with the Company in one or more of its
primary businesses or compete with the Company for management talent. Those
which are not direct competitors are in closely-related fields. The Compensation
Committee takes into account both the size and performance of the Company
relative to the size and performance of the companies in the compensation
comparator group. It also considers the competitiveness of the entire
compensation package of the Company's executive officers compared to the
compensation comparator group. The Compensation Committee regularly reviews the
composition of the compensation comparator group and updates the group
periodically. For fiscal year 2000, the Compensation Committee established
target salaries for executive officers which approximated the 50th percentile or
median level of benchmarked positions with the compensation comparator group. An
individual executive officer's actual salary versus the established target
salary depends upon the executive officer's performance, as judged by her or his
immediate superior and the chief executive officer. The chief executive
officer's performance is judged by the Compensation Committee. The performance
of the other five executive officers who serve as members of the management
executive committee is judged by the chief executive officer and the
Compensation Committee together.

EXECUTIVE INCENTIVE COMPENSATION PLAN. For fiscal year 2000, the EIC Plan
established a linkage between the annual bonus awards and both the Company's
performance and the performance of the executive officers. The Compensation
Committee believes that awards under the EIC Plan should include a reward for
superior performance and an element of adverse consequences for poor financial
results, including no EIC Plan award funding for the Company's financial
performance component described below unless the Company achieves corporate
financial performance measures previously established by the Compensation
Committee.

For the EIC Plan, the Compensation Committee divided the executive officer group
into two subcategories: the executive officers who serve as members of the
management executive committee and the other executive officers. As of June 30,
2000, the six executive officers serving as members of the management executive
committee were G. Craig Sullivan, Chairman of the Board and Chief Executive
Officer, Gerald E. Johnston, President and Chief Operating Officer, Peter D.
Bewley, Senior Vice President -- General Counsel and Secretary, Lawrence S.
Peiros, Group Vice President, Richard T. Conti, Group Vice President, and Karen
M. Rose, Group Vice President -- Chief Financial Officer. For the management
executive committee members, 75% of the EIC Plan award was determined by
achieving corporate financial performance measures previously established by the
Compensation Committee based on a computation consisting of targeted operating
margin level, asset turnover rate and net sales growth. Although sales, profit
and operating margin were all up versus prior year, the Company did not reach
the internal corporate financial measures that were established at the beginning
of fiscal year 2000. The management executive committee members therefore
received no payment with respect to the corporate portion of their EIC award.

The remaining 25% of the EIC Plan award was based on achieving pre-established
individual objectives related to goals that may not be measured by traditional
accounting tools, including completion of the Company's 2005 strategic plan and
the integration of the First Brands acquisition. Individual objectives and the
weight given each individual objective were the same for the members of the
management executive committee.

The target EIC Plan award for the management executive committee members ranged
from 50-80% of base annual salary at June 30, 2000 (100% for the chief executive
officer) if the corporate financial performance and individual objectives were
achieved. The maximum EIC Plan award was 100%-160% of base annual salary at
June 30, 2000 (200% for the chief executive officer) if the goals were
substantially exceeded, and the minimum EIC Plan award was 0 if the goals came
in substantially lower than the targets. All EIC Plan awards are determined by
the chief executive officer and the Compensation Committee or, in the chief
executive officer's case, by the Compensation Committee. Although performance
against the individual objectives described above would have warranted payment
of EIC Plan awards to the members of the management executive committee, the
members requested, and the Compensation Committee exercised its discretion to
determine, that no awards be made and that the cash amounts otherwise earned be
added to the overall incentive pool for distribution to the rest of the
Company's bonus eligible employees. The EIC Plan awards to members of the
executive officer group, other than the management executive committee members,
were determined based on (i) the same corporate financial performance measures
as the management executive committee; and (ii) achieving individual objectives,
including, for operating division officers, operating division financial
performance measures and other individual objectives, and for staff executive
officers, individual objectives, such as the achievement of selected strategic
goals and the successful development of human resources. Individual objectives
and the weight given each individual objective varied from person to person
depending on job responsibilities. The target EIC Plan award for these other
members of the executive officer group was 40%-60% of base annual salary at
June 30, 2000 if goals were achieved up to a maximum of 80%-120% if the goals
were substantially exceeded and down to a minimum of 0 if the goals came in
substantially lower than the targets. While no award was made to the
non-management executive committee executive officers with respect to the
corporate measures, they received special non-EIC Plan cash awards from the
augmented general incentive pool described above.

LONG-TERM COMPENSATION. A major goal of the Compensation Committee is to create
strong alignment between the executive officers and stockholders. This alignment
is achieved through the design of incentive plans and through actual stock
ownership. In furtherance of this goal, the Compensation Committee approved a
3-year grant to all executive officers in May 1999, intended to replace smaller
grants in 1999, 2000 and 2001. In light of the fiscal year 1999 long-term grant,
long-term compensation was awarded only to executive officers receiving
promotions or increases in responsibility during fiscal year 2000, or in other
special circumstances. Those awards consisted of stock options and performance
units issued at market and/or at a premium to market price on the date of the
grant.

The Compensation Committee has endorsed target stock ownership levels by
executive officers to be achieved within five years of becoming an executive
officer. The levels are the equivalent of four times base annual salary for the
chief executive officer and the president, three times base annual salary for
the other executive officers who serve as members of the management executive
committee, and two times base annual salary for other executive officers. No
stock options will be counted in determining ownership levels, which will be
based on shares of Common Stock held, including restricted stock, performance
shares, performance units and shares held via The Clorox Company Employee
Retirement Investment Plan, a profit sharing plan with 401(k) features. All
executive officers have achieved their target stock ownership levels, except
those who have not yet reached five years' tenure.

BENEFITS. The Company provides various employee benefit programs to its
executive officers, including medical and life insurance benefits, retirement
benefits, an employee stock purchase plan and The Clorox Company Employee
Retirement Investment Plan. Except for the Supplemental Executive Retirement
Plan and the Nonqualified Deferred Compensation Plan described on page 19, these
benefit programs are generally available to all employees of the Company.

CHIEF EXECUTIVE OFFICER COMPENSATION. The Compensation Committee increased
Mr. Sullivan's base annual salary on October 1, 1999 from $900,000 to $950,000.
In determining the amount of Mr. Sullivan's salary increase for fiscal year
2000, the Compensation Committee took into

consideration the Company's overall performance for fiscal year 1999. The
Company's achievements for fiscal year 1999 included a total stockholder return
of 47%, and completion of the First Brands merger, including a significant
portion of the integration work, while delivering financial results that
exceeded plan. Mr. Sullivan's salary increase was also determined based on
parity to the median level of comparable positions in the compensation
comparator group and his tenure as chief executive officer.

Mr. Sullivan's EIC Plan award for fiscal year 2000 was based upon the weighted
corporate financial performance measures (75%) and individual objectives (25%)
established by the Compensation Committee as described above. Based on these
measures and objectives, Mr. Sullivan's performance would have warranted a
payment of $296,900. As noted above, Mr. Sullivan and the other members of the
management executive committee requested the Compensation Committee to exercise
its discretion not to make awards in order to increase the incentive pool
available for distribution to the rest of the Company's bonus eligible
employees.

The Compensation Committee did not treat Mr. Sullivan's EIC Plan award
differently from other members of the management executive committee.

ONGOING REVIEW OF COMPENSATION. The Company's compensation consulting firm
conducts an ongoing review of the Company's existing executive compensation
programs for the Compensation Committee to continue to ensure the programs
support the future direction of the Company and the principles on which
executive compensation is based. The Compensation Committee reserves the right
to select and/or to meet independently with any consultant at its discretion.
The Compensation Committee has access to and reviews independent compensation
data relating to executive compensation at other companies. The Compensation
Committee has developed performance goals, which have been approved by the
Company's stockholders, to qualify the bulk of the EIC Plan awards and all
stock-based long-term compensation to the five highest paid executive officers
for exclusion from the federal $1 million tax deductibility limit pursuant to
Section 162(m) of the Internal Revenue Code of 1986, as amended. The
Compensation Committee's policy seeks to balance the interests of the Company in
maintaining flexible incentive plans and how the Company benefits from the
compensation package paid to any executive officer against the possible loss of
a tax deduction when taxable compensation for any of the five highest paid
executive officers exceeds $1 million per year.

Dean O. Morton, Chair Juergen Manchot
Ursula Fairchild Lary R. Scott
Tully M. Friedman

(Members of the Compensation Committee)

COMPENSATION INTERLOCKS AND INSIDER PARTICIPATION

The members of the Compensation Committee for the prior fiscal year were
directors Fairchild, Friedman, Manchot, Morton and Scott. None of these persons
is or has been an officer or employee of the Company or any of its subsidiaries.
In addition, there are no Compensation Committee interlocks between the Company
and other entities involving the Company's executive officers and board members
who serve as executive officers of such entities.

SUMMARY COMPENSATION TABLE

The following table sets forth the compensation for each of the last three
fiscal years earned by or paid or awarded to the chief executive officer of the
Company, the four other most highly compensated executive officers of the
Company and Peter N. Louras, who ceased to be an executive officer on March 1,
2000 (the "Named Officers").

LONG-TERM COMPENSATION
---------------------------------------
AWARDS
--------------------------
ANNUAL COMPENSATION RESTRICTED SECURITIES PAYOUTS
------------------------------------- STOCK UNDERLYING ----------
OTHER ANNUAL AWARD(S) OPTIONS/ LTIP
SALARY BONUS COMPENSATION ($)(1)(2) SARS PAYOUTS
NAME AND PRINCIPAL POSITION YEAR ($) ($)(1) ($)(2) (3)(4) (#)(2)(4) ($)(4)(5)
- --------------------------- -------- -------- ---------- ------------- ---------- ------------- ----------

G. Craig Sullivan.......... 2000 $937,500 $ 0 $63,030 $ 0 0 $ 198,421
Chairman of the Board and 1999 $875,000 $1,186,000 $ 0 $ 0 1,200,000 $4,009,779
Chief Executive Officer 1998 $781,250 $1,117,000 $ 0 $ 0 0 $ 114,337

Gerald E. Johnston......... 2000 $537,499 $ 0 $ 0 $ 0 0 $ 43,317
President and Chief 1999 $410,417 $ 419,600 $ 0 $ 0 372,800 $ 751,817
Operating Officer 1998 $313,750 $ 340,400 $ 0 $ 0 0 $ 11,638

Peter N. Louras............ 2000 $375,000 $ 76,200 $ 0 $ 0 0 $ 39,418
Former Group Vice 1999 $347,500 $ 321,400 $ 0 $ 0 184,200 $ 995,257
President 1998 $320,000 $ 340,400 $ 0 $ 0 0 $ 15,406

Anthony W. Biebl........... 2000 $276,667 $ 198,100 $ 0 $ 0 10,200 $ 10,534
Senior Vice President -- 1999 $255,000 $ 179,000 $ 0 $ 0 82,400 $ 461,741
Product Supply 1998 $237,500 $ 200,500 $ 0 $19,959 0 $ 7,148

Frank A. Tataseo........... 2000 $267,000 $ 178,500 $ 0 $ 0 10,200 $ 10,625
Senior Vice President -- 1999 $250,000 $ 180,800 $ 0 $ 0 80,800 $ 513,670
Sales 1998 $250,000 $ 158,200 $ 0 $15,757 0 $ 7,951

Glenn R. Savage............ 2000 $242,500 $ 138,000 $ 0 $ 0 40,000 $ 7,600
Vice President -- General 1999 $213,000 $ 165,800 $ 0 $ 0 75,200 $ 115,766
Manager, Glad Products 1998 $184,766 $ 130,500 $ 0 $ 0 20,170 $ 896

ALL OTHER
COMPENSATION
NAME AND PRINCIPAL POSITION ($)(6)
- --------------------------- -------------

G. Craig Sullivan.......... $ 67,994
Chairman of the Board and $149,754
Chief Executive Officer $200,761
Gerald E. Johnston......... $ 31,052
President and Chief $ 58,367
Operating Officer $ 70,705
Peter N. Louras............ $ 20,658
Former Group Vice $ 52,562
President $ 74,376
Anthony W. Biebl........... $ 15,289
Senior Vice President -- $ 35,882
Product Supply $ 47,649
Frank A. Tataseo........... $ 14,808
Senior Vice President -- $ 31,963
Sales $ 48,078
Glenn R. Savage............ $ 13,534
Vice President -- General $ 26,880
Manager, Glad Products $ 31,852

- ---------

(1) Pursuant to the EIC Plan, in fiscal year 1998, executive officers were able
to elect some or all of their annual bonus plan awards in Common Stock
rather than cash. Those executive officers electing stock received a premium
equal to 10% of the gross amount elected to be paid in Common Stock based on
the fair market value on September 1, 1998. Such stock awards are subject to
transfer restrictions for two years from the date of grant or the premium
will be forfeited. The premium is included in the Restricted Stock Awards
column in the Long-Term Compensation portion of this table. The net number
of shares and value of the EIC Plan annual bonus amounts paid in Common
Stock awards, after deductions to the base awards made for income tax
purposes, were as follows for fiscal year 1998, -- 0 shares ($0) for
Messrs. Sullivan, Louras, Johnston and Savage; base award -- 2,120 shares
($101,230) and premium -- 418 ($19,959) for Mr. Biebl; and base award --
1,638 ($78,214) and premium -- 330 ($15,757) for Mr. Tataseo. The bonus
amounts include a holiday bonus of $200 per person in each year for fiscal
years 1998 and 1999. The holiday bonus was discontinued in fiscal year 2000.

(2) Amounts include awards earned for the years indicated. To continue its
objective of focusing the executive officers on creation of stockholder
value and in anticipation of the expiration of fiscal year 1996 awards, the
Compensation Committee approved a new 3-year grant of stock options and
performance units to all executive officers in fiscal year 1999. Other
Annual Compensation did not exceed the lesser of either $50,000 or 10% of
the total of annual salary and bonus reported for any Named Officer with the
exception of Mr. Sullivan. He received perquisites with a value of $63,030,

broken out as follows: use of corporate transportation ($57,262); cellular
phone ($1,768) and financial planning ($4,000).

(3) The value of all restricted stock awards set forth in the table above was
determined by multiplying the fair market value of the Common Stock on the
date of grant by the number of shares awarded. As of June 30, 2000, the
number and value of aggregate restricted stock award holdings, based on the
fair market value of $44.8125 on June 30, 2000, were as follows: 0 shares
($0) for Messrs. Sullivan, Johnston and Louras; 418 shares ($18,732) for
Mr. Biebl; 330 shares ($14,788) for Mr. Tataseo; and 3,872 shares ($173,514)
for Mr. Savage. Dividends are paid on shares of restricted stock awarded
commencing from the date of grant.

(4) In the event of a "change of control," "business combination," or complete
liquidation or dissolution of the Company, all restrictions on restricted
stock and performance units end and all stock options become exercisable. A
change of control generally will be deemed to occur if any person or entity
becomes the beneficial owner, directly or indirectly, of a specified
percentage of the then outstanding shares of Common Stock or has, directly
or indirectly, a specified percentage of the combined voting power of the
then outstanding securities entitled to vote for directors. For all persons
or entities other than Henkel KGaA, the specified percentage is 20%. For
Henkel KGaA, the specified percentage is that agreed to between the Company
and Henkel KGaA pursuant to the Letter Agreement, which currently is 30%.
See "Certain Relationships and Transactions" on page 9. A business
combination generally will be deemed to occur in the event of a
reorganization, merger or sale of substantially all of the assets of the
Company, subject to certain exceptions. A feature of the Stock Incentive
Plan is the stock withholding election, pursuant to which a recipient may
elect to have the Company withhold shares of Common Stock to pay any
withholding tax liability that arises when the restrictions on the
restricted stock are released or when non-qualified stock options are
exercised, respectively. In both cases, the value of shares which may be
withheld is based on the per share price of the Common Stock on the
Composite Transactions Report for the New York Stock Exchange on the last
business day before the withholding is made.

(5) The amounts reflect dividends received from deferred stock units granted in
December 1995 and from performance units granted between April 1996 and
September 1999. In addition, the amounts for fiscal year 1999 include the
value of performance units granted between April 1996 and March 1998, which
vested on June 30, 1999. Based on their value on the earliest settlement
date of August 17, 1999, the number and value of the vested performance
units granted between April 1996 and March 1998 were as follows: 95,536
units ($3,881,150) for Mr. Sullivan; 18,184 units ($738,725) for
Mr. Johnston; 24,072 units ($977,925) for Mr. Louras; 11,168 units
($453,700) for Mr. Biebl; 12,424 units ($504,725) for Mr. Tataseo, and 2,800
units ($113,750) for Mr. Savage.

(6) Except for amounts received under the Nonqualified Deferred Compensation
Plan, the amounts shown in the column are pursuant to programs provided to
salaried employees generally and represent actual Company contributions
under the Company's Employee Retirement Investment Plan and the Nonqualified
Deferred Compensation Plan, and term life insurance premiums paid by the
Company for the benefit of each respective Named Officer, respectively, in
the following amounts: for fiscal year 2000, $4,800, $58,899 and $4,295 for
Mr. Sullivan; $5,800, $23,907 and $1,345 for Mr. Johnston; $5,800, $14,117
and $741 for Mr. Louras; $5,800, $8,864 and $625 for Mr. Biebl; $5,800,
$8,618 and $390 for Mr. Tataseo; and $5,800, $7,443 and $291 for
Mr. Savage; for fiscal year 1999, $11,200, $137,304 and $1,350 for
Mr. Sullivan; $11,950, $45,667 and $750 for Mr. Johnston; $11,950, $40,049
and $563 for Mr. Louras; $12,200, $22,735 and $947 for Mr. Biebl; $12,920,
$18,491 and $552 for Mr. Tataseo; and $12,200, $14,354 and $326 for
Mr. Savage; for fiscal year 1998, $11,200, $188,361 and $1,200 for
Mr. Sullivan; $11,950, $58,267 and $488 for Mr. Johnston; $11,950, $61,938
and $488 for Mr. Louras; $11,950, $35,049 and $650 for Mr. Biebl; $19,310,
$28,281 and $487 for Mr. Tataseo; and $11,950, $19,629 and $273 for
Mr. Savage.

OPTIONS AND STOCK APPRECIATION RIGHTS

The following tables show options and stock appreciation rights ("SARs") granted
or exercised during fiscal year 2000 to or by the Named Officers, and the value
of the options and SARs held by the Named Officers at the end of fiscal year
2000.

OPTIONS/SAR GRANTS IN LAST FISCAL YEAR

POTENTIAL REALIZABLE VALUE AT
ASSUMED ANNUAL RATES OF
STOCK PRICE APPRECIATION FOR
INDIVIDUAL GRANTS OPTION TERM(3)
------------------------------------------ --------------------------------
% OF TOTAL
NUMBER OF OPTIONS/
SECURITIES SARS
UNDERLYING GRANTED TO EXERCISE OR
OPTIONS/SARS EMPLOYEES IN BASE PRICE EXPIRATION
NAME GRANTED(#)(1) FISCAL YEAR(2) ($/SHARE)(1) DATE(1) 0%(4) 5%(4) 10%(4)
- ---- ------------- -------------- ------------ ---------- -------- -------- ----------

G. Craig Sullivan.......... 0 -- -- -- -- -- --

Gerald E. Johnston......... 0 -- -- -- -- -- --

Peter N. Louras............ 0 -- -- -- -- -- --

Anthony W. Biebl........... 1,400 0.05% $43.2500 09/15/10 -0- $ 38,080 $ 96,501
1,400 0.05% $47.5750 09/15/10 -0- $ 41,888 $ 106,151
1,400 0.05% $54.0625 09/15/10 -0- $ 47,599 $ 120,626
6,000 0.19% $67.3828 12/31/06 -0- $254,260 $ 644,345

Frank A. Tataseo........... 1,400 0.05% $43.2500 09/15/10 -0- $ 38,080 $ 96,501
1,400 0.05% $47.5750 09/15/10 -0- $ 41,888 $ 106,151
1,400 0.05% $54.0625 09/15/10 -0- $ 47,599 $ 120,626
6,000 0.19% $67.3828 12/31/06 -0- $254,260 $ 644,345

Glenn R. Savage............ 40,000 1.3% $35.7812 04/26/10 -0- $900,105 $2,281,044

- ---------

(1) In fiscal year 1999, the Compensation Committee approved three-year front
loaded grants to each executive officer. The stock option grants continued
the Compensation Committee's past practice of targeting overall compensation
to the 50th percentile of comparable positions from the compensation
comparator group (as described in the Compensation Committee Report on page
9). The Compensation Committee granted additional stock options (the
"Additional Stock Options") to each executive officer which would have the
possibility of lifting the executive officer's stock-based compensation
component from the 50th to the 75th percentile. In fiscal year 2000, long
term incentive compensation was awarded only to those executive officers
receiving a promotion or increase in responsibility or in other special
circumstances. Messrs. Biebl and Tataseo were promoted during the year.
Their fiscal year 2000 awards enhanced the grants they received in fiscal
year 1999, keeping their long term incentive compensation in line with the
targets described above. Except for the Additional Stock Options, the stock
options awarded to Messrs. Biebl and Tataseo in fiscal year 2000 had
ten-year lives, and one-third of the number of option shares will vest on
each of June 30, 2001, 2002, and 2003. Option shares vesting on June 30,
2001 have an exercise price of $43.25, the fair market value on the option
grant date. Option shares vesting on June 30, 2002 and 2003 have exercise
prices of $47.575 and $54.0625, premiums of 10% and 25%, respectively, over
the $43.25 fair market value on the option grant date. The Additional Stock
Options will vest in six years, on June 30, 2006, but could vest earlier
based on the relative total stockholder return (stock price appreciation
plus dividends paid) of the Common Stock measured against the total
stockholder return of an index of stocks of a financial

comparator group of 24 consumer products companies. If, on average, the
Company's total stockholder return is at or above the 75th percentile
relative to the stockholder return of the financial comparator group as
measured at the end of fiscal year 2001, 50 percent of the Additional Stock
Options will vest on June 30, 2001. If, on average, the Company's total
stockholder return is at or above the 75th percentile relative to the
stockholder returns of the financial comparator group as measured at the end
of fiscal year 2002, 100 percent (or 50 percent if 50 percent vested on
June 30, 2001) of the Additional Stock Options will vest on June 30, 2002.
Any Additional Stock Options that vest on June 30, 2001 or June 30, 2002,
will not expire until May 6, 2009. Any Additional Stock Options that vest on
June 30, 2006 will expire on December 31, 2006. The stock options granted to
Mr. Savage in fiscal year 2000 have a ten-year life, and one half of the
number of option shares will vest on each of June 30, 2001 and June 30,
2002. The options have an exercise price of $35.78125, the fair market value
on the date of grant. In the event of a "change of control" (as described in
footnote (4) to the Summary Compensation Table on page 14), all stock
options become exercisable.

(2) The total number of options/SARs granted to employees of the Company in
fiscal year 2000 represented 3,079,896 shares of Common Stock. The potential
realizable value (excluding dividends) of such options at assumed annual
rates of appreciation of 5% and 10% from the dates of their respective
grants to the end of the option terms using the appropriate prices above
would be $76,429,210 and $193,686,625, respectively.

(3) The 5% and 10% assumed rates of appreciation are shown in response to
requirements of the rules of the Securities and Exchange Commission. There
can be no assurance that the market value of the Common Stock will
appreciate in the assumed manner. The column reflecting no appreciation in
market value is intended for illustrative purposes only. The market value of
the Common Stock on September 15, 1999 and April 26, 2000, the dates of
grant of the above options, was $43.25 and $35.78 per share, respectively.

(4) Based on the fair market value of $44.8125 of the outstanding shares of
Common Stock on June 30, 2000 and not including dividends, the potential
realizable value at assumed annual rates of Common Stock appreciation of 5%
and 10% for a ten-year period for all stockholders would be $7,040,707,711
and $17,842,535,697, respectively. The potential realizable value at assumed
annual rates of appreciation of 5% and 10% on the options of the Named
Officers from the date of grant to the end of the ten-year option terms
would be $1,663,758 and $4,216,291, respectively. Thus, the Named Officers'
potential realizable value as a percentage of all stockholders' gain would
be 0.02% in the event of a 5% assumed annual rate of appreciation and 0.02%
in the event of a 10% assumed annual rate of appreciation. Further, the
potential realizable value of all employee options as a percentage of all
stockholders' gain would be 1.09% in the event of a 5% assumed annual rate
of appreciation and 1.09% in the event of a 10% assumed annual rate of
appreciation over the ten-year option terms.

AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR
AND FY-END OPTION/SAR VALUES

NUMBER OF SECURITIES
UNDERLYING UNEXERCISED VALUE OF UNEXERCISED
OPTIONS/SARS AT FY-END IN-THE-MONEY OPTIONS/SARS
SHARES ACQUIRED VALUE (#) EXERCISABLE/ AT FY-END ($) EXERCISABLE/
NAME ON EXERCISE(#) REALIZED($) UNEXERCISABLE(1) UNEXERCISABLE(1)(2)
- ---- --------------- ----------- ---------------------- --------------------------

G. Craig Sullivan....... 0 0 1,469,392/1,200,000 $ 36,414,864/$0
Gerald E. Johnston...... 0 0 242,512/372,800 $ 5,742,088/$0
Peter N. Louras......... 416,640 $8,805,320 51,376/184,200 $ 1,054,814/$0
Anthony W. Biebl........ 11,928 $ 380,019 229,516/92,600 $ 6,190,264/$2,188
Frank A. Tataseo........ 0 0 220,868/91,000 $ 5,808,865/$2,188
Glenn R. Savage......... 0 0 66,644/117,590 $1,514,098/$382,163

- ---------

(1) The number of shares covered and the value of the unexercisable options
listed relate to stock options granted under the 1987 Stock Option Plan or
the 1996 Stock Incentive Plan. In the event of a "change of control,"
"business combination" or complete liquidation or dissolution of the Company
(as described in footnote (4) to the Summary Compensation Table on page 14),
all stock options become exercisable.

(2) The value of the unexercised options was determined by multiplying the
number of shares subject to unexercised options on the fiscal year end,
June 30, 2000, by $44.8125, the fair market value of the Common Stock on
such date, minus the exercise price of each unexercised option.

LONG-TERM INCENTIVE PLANS -- AWARDS IN LAST FISCAL YEAR

The table below reflects awards to the Named Officers during fiscal year 2000
under the 1996 Stock Incentive Plan. If conditions are met, such awards are
redeemable in shares of Common Stock.

NUMBER OF SHARES, UNITS OR OTHER PERFORMANCE OR OTHER PERIOD UNTIL MATURATION
NAME RIGHTS (#)(1) OR PAYMENT (2)
- ---- -------------------------------- --------------------------------------------

G. Craig Sullivan............ 0 --
Gerald E. Johnston........... 0 --
Peter N. Louras.............. 0 --
Anthony W. Biebl............. 1,300 6/30/02, 6/30/03 or Forfeited
Frank A.Tataseo.............. 1,300 6/30/02, 6/30/03 or Forfeited
Glenn R. Savage.............. 0 --

- ---------

(1) To continue its objective of focusing the executive officers on creation of
stockholder value, the Compensation Committee approved a three-year grant of
performance units to all executive officers in fiscal year 1999. In
September 1999, Messrs. Biebl and Tataseo received grants in recognition of
promotions received in fiscal year 2000. The September 1999 grants could
vest on June 30, 2002 based on the relative total stockholder return (stock
price appreciation plus dividends paid) of the Common Stock measured against
two comparator groups: first, the total stockholder return of the companies
included in Standard & Poor's 500 Stock Index and second, the total
stockholder return of an index of stocks of the financial comparator group
(as described in footnote (1) to the Options/SAR Grants Table on page 15).
If the Company's total stockholder return is at or above the 60th percentile
relative to the stockholder returns of the two groups as measured at the end
of fiscal year 2002, the performance units will vest on that day. If the
performance units do not vest on that date and the Company's total
stockholder return is at or above the 50th percentile at the end of fiscal
year 2003, the performance units will vest at that time. If, at the end of
fiscal year 2003, the Company's total stockholder return is at or above the
40th percentile, but below the 50th percentile, half of the performance
units will vest and the other half will be forfeited. If, at the end of
fiscal year 2003, the Company's total stockholder return is below the 40th
percentile, all of the performance units will be forfeited. The performance
units are redeemable in an equal number of shares of Common Stock.

(2) In the event of a "change of control" (as described in footnote (4) to the
Summary Compensation Table on page 14), all performance units become
exercisable.

COMPARATIVE STOCK PERFORMANCE

The graph below compares the cumulative total stockholder return of the Common
Stock for the last five fiscal years with the cumulative total return of the
Standard & Poor's 500 Stock Index and a composite index composed of the
Standard & Poor's Household Products Index and the Standard & Poor's Housewares
Index for a five-year period ending June 30, 2000. The composite index is
weighted based on market capitalization as of the end of each quarter during
each of the last five years. The graph lines merely connect the prices on the
dates indicated and do not reflect fluctuations between those dates.

EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC

THE CLOROX COMPANY S & P 500 PEER GROUP

6/95 100.00 100.00 100.00
6/96 139.73 126.00 126.70
6/97 213.04 169.73 184.21
6/98 313.66 220.92 228.43
6/99 355.11 271.19 238.88
6/00 303.48 290.85 187.09

The foregoing report of the Compensation Committee of the board of directors on
executive compensation and the performance graph that appears immediately above
shall not be deemed to be soliciting material or to be filed under the
Securities Act of 1933 or the Securities Exchange Act of 1934, or incorporated
by reference in any document so filed.

PENSION BENEFITS

Pension benefits are paid to executive officers under three different plans: the
Pension Plan, the Nonqualified Deferred Compensation Plan and the Supplemental
Executive Retirement Plan ("SERP").

The Company's Pension Plan is a noncontributory "cash balance" defined benefit
plan qualified under pertinent income tax laws. Essentially, all salaried
employees, as well as nonunion hourly employees with at least one year of
service, participate in the Pension Plan. Prior to July 1, 1996, benefits were
calculated based on career average compensation. Effective July 1, 1996,
participants in the plan accrue benefits equal to 3% of qualified earnings each
year. Qualified earnings include base annual salary and bonus. Participants'
benefits are adjusted each quarter by an interest factor. Participants meeting
certain age and years of service levels will receive the greater of the benefits
calculated under the career average compensation formula and the cash balance
formula. Except for Mr. Tataseo and Mr. Savage, who will

receive benefits calculated under the cash balance formula, each of the Named
Officers met the age and years of service levels and will receive the greater of
the benefits under the current and prior formulas. A participant is fully vested
in her or his benefit after 5 years of service.

The Nonqualified Deferred Compensation Plan provides additional benefits equal
to the employer-provided benefits that plan participants do not receive under
the Pension Plan because of Internal Revenue Code limits. This plan has the same
five-year vesting provision as the Pension Plan.

The purpose of the SERP is to provide executive officers a fixed objective of
55% of the average annual compensation for the three consecutive years of
highest compensation. Compensation consists of base annual salary and the EIC
Plan bonus. For the Named Officers, those amounts are shown in the salary and
bonus columns of the Summary Compensation Table on page 13. There is a minimum
service requirement of ten years. SERP benefits are offset by the annuity value
of amounts received from primary social security, the Pension Plan and Company
contributions to the Employee Retirement Investment Plan and Nonqualified
Deferred Compensation Plan.

Assuming retirement at age 65, fiscal year 2000 annual base salary and bonus and
no future increase in such compensation and an interest rate of 8%, the SERP
benefits for the Named Officers will exceed benefits under the other plans. The
retirement benefits shown in the table below are based on the SERP, calculated
for an unmarried person, on a straight life annuity basis, based on retirement
at age 65 with 15 or more years of service with the Company. They would be
proportionately reduced for early retirement or for shorter years of service to
a minimum of 10 years. Thus, the table below shows what would be received by the
Named Officers under the three plans for pension benefits, taken collectively.

15 OR MORE
COMPENSATION(1) YEARS OF SERVICE
- --------------- ----------------

$400,000.................................................... $ 220,000
$500,000.................................................... $ 275,000
$600,000.................................................... $ 330,000
$700,000.................................................... $ 385,000
$800,000.................................................... $ 440,000
$900,000.................................................... $ 495,000
$1,000,000.................................................. $ 550,000
$1,100,000.................................................. $ 605,000
$1,200,000.................................................. $ 660,000
$1,300,000.................................................. $ 715,000
$1,400,000.................................................. $ 770,000
$1,500,000.................................................. $ 825,000
$1,600,000.................................................. $ 880,000
$1,700,000.................................................. $ 935,000
$1,800,000.................................................. $ 990,000
$1,900,000.................................................. $1,045,000
$2,000,000.................................................. $1,100,000
$2,100,000.................................................. $1,155,000
$2,200,000.................................................. $1,210,000
$2,300,000.................................................. $1,265,000

- ---------

(1) The number of years of credited service for each of the Named Officers are:
Mr. Sullivan, 29; Mr. Johnston, 19; Mr. Louras, 20; Mr. Biebl, 19;
Mr. Tataseo, 6; and Mr. Savage, 17.

EMPLOYMENT AGREEMENTS AND OTHER ARRANGEMENTS

The Company has entered into employment agreements with each of the Named
Officers named in the Summary Compensation Table on page 13 above, other than
Mr. Louras. The term of the employment agreement for Mr. Sullivan is five years,
for Mr. Johnston is three years, and for Messrs. Biebl, Tataseo and Savage is
two years. Such agreement terms are "evergreen" in that they maintain a
five-year term, in the case of the chief executive officer, a three-year term,
in the case of Mr. Johnston, and a two-year term in the case of Messrs. Biebl,
Tataseo and Savage, unless either party gives five-years' notice of termination,
in the case of the chief executive officer's employment agreement, three-years'
notice of termination, in the case of Mr. Johnston's employment agreement, and
two-years' notice of termination, in the case of Messrs. Biebl, Tataseo and
Savage's employment agreements. The employment agreements are also terminable at
any time by the Company for "Cause," as that term is defined in them, or "at
will" by either the officer or the Company. In the case of an "at will"
termination by the Company, an officer is entitled to receive annually severance
benefits of his then current base salary, plus 75% of his target EIC Plan award
for the previous fiscal year, for the length of the remaining term of his
employment agreement, subject to offset for other earned income. The employee
agreements provide that the officer is entitled to continue to participate in
the Company's medical and dental insurance programs for the same period. In
addition, the officer would receive a pro-rated EIC Plan award for the year in
which termination occurs. Mr. Peter N. Louras's employment with the Company
terminated effective July 1, 2000. In accordance with his employment agreement,
he is receiving semi-monthly payments of $15,625 through February 28, 2003,
which will be reduced by any other earned income, and he is entitled to continue
participation in the Company's medical and dental insurance programs during the
same time period.

The Company has entered into change of control agreements with each of the Named
Officers, other than Mr. Louras. Within a three-year period, in the cases of
Mr. Sullivan and Mr. Johnston, or a two-year period in the case of
Messrs. Biebl, Tataseo and Savage, of a "change of control," "business
combination" or complete dissolution or liquidation of the Company (as described
in footnote (4) to the Summary Compensation Table on page 14), an officer may
terminate his employment in the event of a reduction or elimination in rank,
responsibilities, compensation or benefits, and he may also terminate his
employment absent such reasons within a 30-day period following the first
anniversary of the change of control. In the event of such termination, the
officer will receive a lump sum amount equal to his then current base salary,
plus 100% of his target EIC Plan award for the then current fiscal year,
multiplied by the change of control benefit multiple under the change of control
agreements. For Messrs. Sullivan and Johnston, such multiple is three, and for
Messrs. Biebl, Tataseo and Savage, such multiple is two. In addition, an officer
is entitled to continue to participate in the Company's medical and dental
insurance programs for the remaining term of his change of control agreement.
The officer would also receive a pro-rated EIC Plan award for the year in which
termination occurs. If payments received under the change of control agreements
are subject to tax under Section 4999 of the Internal Revenue Code of 1986, as
amended (which deals with certain payments contingent on a change of control),
the Company will make an additional payment to the officer in respect of such
tax.

The Company has also entered into employment agreements and change of control
agreements on similar terms with each of the other executive officers of the
Company. The termination notice periods for these agreements range from three
years to one year depending upon the executive officer's level in the
organization and her or his tenure as an executive officer.

SECTION 16 BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 and Securities and Exchange
Commission regulations require the Company's directors, certain officers and
greater than ten percent stockholders to file reports of ownership on Form 3 and
changes in ownership on Forms 4 or 5 with the Securities and Exchange
Commission. The Company undertakes to file such forms on behalf of the reporting
directors or officers pursuant to a power of attorney given to certain
attorneys-in-fact. The reporting officers, directors and ten

percent stockholders are also required by Securities and Exchange Commission
rules to furnish the Company with copies of all Section 16(a) reports they file.

Based solely on its review of copies of such reports received or written
representations from such executive officers, directors and ten percent
stockholders, the Company believes that all Section 16(a) filing requirements
applicable to its directors, executive officers and ten percent stockholders
were complied with during fiscal year 2000, except the following: Mr. Tully M.
Friedman filed a Form 4 in May 2000 to disclose sixteen purchase transactions
made between May 1999 and March 2000 through trust accounts managed by an
investment advisor with discretionary authority; Mr. Charles M. Couric filed a
Form 4 in May 2000 to disclose a stock option exercise in March 2000;
Mr. Gregory S. Frank filed an amended Form 3 in August 2000 to disclose a stock
option grant received before he became an executive officer that was
inadvertently omitted from his Form 3 filing; Mr. Glenn R. Savage filed an
amended Form 5 in September 2000 to disclose the disposition of shares in a
stock withholding arrangement in connection with the release of restricted stock
that was inadvertently omitted from his Form 5 filing; and Mr. Frank A. Tataseo
filed a Form 5 in September 2000 to disclose a charitable stock gift that was
previously not reported.

PROPOSAL NO. 2:
RATIFICATION OF CERTIFIED PUBLIC ACCOUNTANTS

The Audit Committee of the board of directors has recommended, and the board of
directors has selected, Deloitte & Touche LLP, certified public accountants, for
the fiscal year ending June 30, 2001. Deloitte & Touche LLP has been so engaged
since 1957. During fiscal year 2000, Deloitte & Touche LLP examined the
Company's consolidated financial statements, made limited reviews of the interim
financial reports, reviewed filings with the Securities and Exchange Commission
and provided general advice regarding related accounting matters.

Ratification of the selection of Deloitte & Touche LLP by stockholders is not
required by law. However, as a matter of policy, such selection is being
submitted to the stockholders for ratification at the Annual Meeting (and it is
the present intention of the board of directors to continue this policy). The
board of directors recommends the adoption of the following resolution which
will be presented at the Annual Meeting:

RESOLVED, that the stockholders of The Clorox Company hereby
ratify the selection of Deloitte & Touche LLP, certified public
accountants, for the fiscal year ending June 30, 2001.

The persons designated in the enclosed proxy will vote your shares FOR
ratification unless instructions to the contrary are indicated in the enclosed
proxy. If the stockholders fail to ratify the selection of this firm, the board
of directors will reconsider the matter. The affirmative vote of a majority of
the shares of Common Stock represented and voted at the Annual Meeting is
required to ratify the selection of Deloitte & Touche LLP.

Representatives of Deloitte & Touche LLP are expected to be present at the
Annual Meeting to respond to appropriate questions and to make a statement
should they desire to do so.

OTHER BUSINESS

The board of directors is not aware of any other matters to come before the
Annual Meeting. If any matter not mentioned herein is properly brought before
the Annual Meeting, the persons named in the enclosed proxy will have
discretionary authority to vote all proxies with respect thereto in accordance
with their judgment and Rule 14a-4 under the Securities Exchange Act of 1934.

OTHER INFORMATION

Consolidated financial statements for the Company are attached as Appendix B to
this proxy statement and are included in the Annual Report on Form 10-K for the
fiscal year ending June 30, 2000 filed with the Securities and Exchange
Commission, 450 Fifth Street, N.W., Washington, D.C. 20549. A copy of the 2000
Form 10-K (excluding exhibits) may be obtained, without charge, by calling
Clorox Shareholder Direct at 1-888-CLX-NYSE (259-6973) toll-free, 24 hours a
day, seven days a week.

SOLICITATION OF PROXIES

The Company has not retained an outside firm in connection with the solicitation
of the enclosed proxy. However, executive officers, directors and regular
employees of the Company, who will receive no extra compensation for their
services, may solicit proxies by telephone, facsimile or personal call.

STOCKHOLDER PROPOSALS FOR 2001 ANNUAL MEETING

Stockholders who may wish to present proposals for inclusion in the Company's
proxy material and for consideration at the 2001 annual meeting must submit such
proposals in writing to the Secretary at the address shown on the top of the
notice accompanying this proxy statement not later than June 1, 2001. Any
proposal submitted with respect to the Company's 2001 Annual Meeting of
Stockholders later than June 1, 2001 will be considered untimely for purposes of
Rule 14a-4 under the Securities Exchange Act of 1934 if notice thereof is
received by the Company later than September 6, 2001.

By Order of the Board of Directors

[SIGNATURE]

Peter D. Bewley,
SENIOR VICE PRESIDENT -- GENERAL
COUNSEL AND SECRETARY

September 29, 2000

APPENDIX A
AUDIT COMMITTEE CHARTER

ROLE AND INDEPENDENCE

The audit committee of the board of directors assists the board in fulfilling
its responsibility for oversight of the quality and integrity of the accounting,
auditing and reporting practices of the corporation and such other duties as
directed by the board. The membership of the committee shall consist of at least
three directors who are generally knowledgeable in financial and auditing
matters, including at least one member with accounting or related financial
management expertise. Each member shall be free of any relationship that, in the
opinion of the board, would interfere with his or her individual exercise of
independent judgment. The committee is expected to maintain free and open
communication (including private executive sessions at least annually) with the
independent accountants, the internal auditors and the management of the
corporation. In discharging this oversight role, the committee is empowered to
investigate any matter brought to its attention, with full power to retain
outside counsel or other experts for this purpose. This charter shall be
reviewed and updated annually.

RESPONSIBILITIES

The audit committee's primary responsibilities include:

- Primary input into the recommendation to the board for the selection and
retention of the independent accountant that audits the financial
statements of the corporation. In the process, the committee will discuss
and consider the auditor's written affirmation that the auditor is in fact
independent, will discuss the nature, rigor, and proposed scope of the
audit process, receive and review all reports and will provide to the
independent accountant full access to the committee (and the board) to
report on any and all appropriate matters.

- Guidance and oversight to the internal audit function of the corporation,
including review of the organization, plans and results of such activity.

- Review of financial statements (including quarterly reports) with
management and the independent auditor. It is anticipated that these
discussions will include quality of earnings, review of reserves and
accruals, consideration of the suitability of accounting principles,
review of highly judgmental areas, audit adjustments whether or not
recorded and such other inquiries as may be appropriate.

- Discussion with management and auditors on the quality and adequacy of the
company's internal controls, policies, procedures and practices.

- Discussion with management of the status of pending litigation, taxation
matters, environmental issues and other areas of oversight to the legal
and compliance area as may be appropriate.

- Reporting on audit committee activities to the full board.

A-1

APPENDIX B

MANAGEMENT'S DISCUSSION AND ANALYSIS

RESULTS OF WORLDWIDE OPERATIONS

CONSOLIDATED RESULTS

DILUTED EARNINGS PER SHARE increased to $1.64 from $1.03 and NET EARNINGS
improved to $394 million from $246 million for the year ended June 30, 2000. The
increase in earnings was principally due to an increase in net sales, cost
savings and a reduction in merger, restructuring and asset impairment costs. The
Company's results reflect the January 29, 1999 merger with First Brands
Corporation ("First Brands"). The merger was accounted for as a pooling of
interests and all historical financial information has been restated to include
First Brands.

NET SALES increased by 2% from 1999 due to a 2% volume increase driven by
product introductions and shipment gains in certain products. These gains were
partly offset by volume losses in the Company's First Brands businesses
resulting from decreased spending for trade promotional support, elimination of
non-core, low-margin items, and changing the pricing structure for the cat
litter business. Products introduced included CLOROX Disinfecting Spray and
Wipes, LIQUID-PLUMR FOAMING PIPE SNAKE drain cleaner, MEADOW FRESH PINE-SOL
cleaner, Ultra CLOROX liquid bleach, CLOROX FRESHCARE dry cleaning care, BRITA
FILL & GO sports bottle, K C MASTERPIECE marinades and new lines of GLADWARE
disposable container products. Volume growth was positively impacted by gains in
shipments of HIDDEN VALLEY Ranch dressing, BRITA faucet-mount filter system, and
KINGSFORD and MATCH LIGHT charcoal products; and the acquisition of the Bon Bril
cleaning utensil and cleaning businesses; the growth was partially offset by
declines in shipments of TILEX FRESH SHOWER daily shower cleaner.

Net sales in 1999 increased by 3% from 1998 due to volume increases in the
Company's businesses (excluding lower sales from former First Brands businesses)
and the acquisition of a business in Korea, partially offset by the unfavorable
mix of certain products sold and currency devaluations. The lower First Brands
sales were mainly the result of the elimination of inefficient trade promotion
practices that had encouraged heavy stocking of inventory by trade customers in
previous years. Record volumes were achieved for the following brands: CLOROX
liquid bleach, FORMULA 409 cleaners, CLOROX CLEAN-UP cleaners, PINE-SOL
cleaners, CLOROX toilet bowl cleaner, TILEX FRESH SHOWER daily shower cleaner,
FRESH STEP and FRESH STEP SCOOP cat litters, KINGSFORD charcoal, HIDDEN VALLEY
dressings and K C MASTERPIECE barbecue sauce. For 1999, significant launches
included CLOROX ADVANTAGE liquid bleach, CLOROX FRESHCARE fabric refresher, and
BRITA faucet-mounted water filters, all in the U.S., and CLOROX liquid bleach in
Brazil.

COST OF PRODUCTS SOLD as a percentage of sales increased to 55.1% in 2000 from
54.5% in 1999 and 54.5% 1998. The increase in cost of products sold as a
percentage of sales from the prior year was primarily due to higher raw material
costs, start-up costs associated with the introduction of products and the
charge of $4 million relating to the write down of the Company's fire logs
inventories to their net realizable value. These increases were partially offset
by cost savings initiatives and trade spending efficiencies in the former First
Brands businesses. Starting in 2000, delivery costs are included in cost of
products sold. Previously such costs were included in selling, delivery and
administration expense but 1999 and 1998 amounts have now been reclassified for
comparative purposes. Reporting delivery costs as cost of products sold had the
impact of increasing cost of products sold, and decreasing gross margin, by six
basis points in years 2000, 1999 and 1998.

Cost of products sold in 1999 reflects the result of numerous cost-savings
projects, including improvements in line production in the U.S. Home Care and
Cleaning businesses, which improved efficiencies by minimizing equipment change
over costs, additional bottle-making capacity added during the year and
improvements in the ARMOR ALL business. These savings offset the effect of
writing off obsolete inventory related to the First Brands businesses totaling
$8 million in 1999.

B-1

SELLING AND ADMINISTRATION EXPENSES, after reclassification of delivery costs as
discussed above, declined by 5% in 2000 due to the on-going benefit of combining
the former First Brands businesses with the Company; savings from lower
commission expense primarily due to the consolidation of the Company's broker
network; the consolidation of the Company's logistic network; and bringing sales
and distribution activities in-house in major Latin America markets. Selling and
administration expense increased 1% to $554 million in 1999 from $548 million in
1998 as the impact of continuing efficiencies exceeded the impact of inflation
and salary rate increases.

ADVERTISING EXPENSE decreased by 2% in 2000 due to an 18% reduction in
sales-promotion spending resulting from the elimination of inefficient promotion
practices on First Brands products. A portion of this savings was re-invested in
media spending which increased 15% compared with the prior year. Advertising
expense declined by 3% in 1999 due to a reduction in sales-promotion spending on
First Brands products that were determined to be ineffective and a shift in
timing of new product advertising spending to 2000.

MERGER, RESTRUCTURING AND ASSET IMPAIRMENT COSTS of $36 million and
$180 million were recognized in 2000 and 1999, respectively. In 2000, the
$36 million included $23 million of First Brands merger-related charges related
to the consolidation of First Brands distribution centers, relocation, and
retention bonuses paid to former First Brands employees; $11 million of
restructuring and asset impairment related to the restructuring of the Company's
Asia operations recognized in the fourth quarter of 2000; and $2 million of
asset impairment losses recognized on property, plant and equipment related to
the Company's fire logs business.

In 1999, the $180 million of merger costs included $36 million of merger-related
charges recognized in connection with the First Brands merger, $53 million of
other restructuring costs and $91 million of provisions for asset impairment.
Restructuring activities in 1999 primarily related to the consolidation of
administration and distribution functions; the reduction in employee headcount
primarily at the First Brands' headquarters location in Danbury, Connecticut and
at sales offices; and the termination of related leases and other contracts.
Asset impairment losses recognized in 1999 were for the write-off of software
development and other costs incurred in connection with the First Brands merger
and the write-down to expected realizable value of certain of the Company's
insecticide and international intangible assets.

INTEREST EXPENSE remained relatively flat year over year. Rising interest rates
offset the effect of refinancing First Brands debt in the prior year. Interest
expense decreased by $7 million in 1999, primarily as a result of refinancing
First Brands debt.

OTHER EXPENSE, NET remained unchanged year over year. Lower amounts of equity
earnings from affiliates and royalty income were mostly offset by decreased
amortization of intangibles and higher interest income. Other expense, net
increased in 1999 primarily due to higher amortization of intangibles; the
effect of currency translation on certain international operations; and
miscellaneous equipment write-downs related to production of CLOROX 2 liquid
bleach.

THE CUMULATIVE EFFECT OF THE CHANGE IN ACCOUNTING PRINCIPLE of $7 million was
recorded in 1998 by First Brands to expense previously capitalized costs related
to business process re-engineering activities (in accordance with the Financial
Accounting Standards Board Emerging Issues Task Force Issue No. 97-13).

THE EFFECTIVE TAX RATE was 36.7%, 42.8% and 37.1% in 2000, 1999 and 1998,
respectively. The higher tax rate in 1999 was primarily attributable to the tax
effect of merger, restructuring and asset impairment costs.

DILUTED EARNINGS PER SHARE increased to $1.64 in 2000 from $1.03 in 1999,
primarily due to lower merger, restructuring and asset impairment costs and to
improved earnings driven by volume growth and cost savings, all as described
above. Merger, restructuring and asset impairment costs had the effect of
reducing diluted earnings per share by $0.11 in 2000, compared with $0.60 in
1999. Diluted earnings per share decreased to $1.03 in 1999 from $1.43 in 1998,
mostly due to merger, restructuring and asset impairment costs, partly offset by
improved earnings in 1999 as compared to 1998, which was primarily attributable
to volume growth and lower advertising expense, as described above.

B-2

SEGMENT RESULTS

U.S. HOUSEHOLD PRODUCTS AND CANADA

2000 vs. 1999: U.S. Household Products and Canada's 2000 net sales increased by
5% while earnings before tax decreased by 2% from 1999 due to higher product
costs and advertising expenditures. The improvement in net sales reflected the
positive impact resulting from the introduction of products which included
CLOROX Disinfecting Spray and Wipes, LIQUID-PLUMR FOAMING PIPE SNAKE drain
cleaner, MEADOW FRESH PINE-SOL cleaner, Ultra CLOROX liquid bleach, CLOROX
FRESHCARE dry cleaning care, BRITA FILL & GO sports bottle, partially offset by
declines in shipments of TILEX FRESH SHOWER daily shower cleaner. Higher resin
and corrugated costs, start-up costs for product launches, a shift in product
costs in the Brita business due to an increase in production of faucet-mount
filter systems introduced in late 1999, and greater costs for additional
components in the BRITA pitchers, all contributed to the increase in cost of
products sold. Advertising expenditures also increased over the prior year due
to the introduction of Ultra CLOROX liquid bleach and other new products.

1999 vs. 1998: U.S. Household Products and Canada's 1999 earnings before tax
increased by 12% from 1998. This increase reflected higher net sales and lower
cost of products sold. The 4% improvement in net sales reflected the positive
impact achieved from record volumes for CLOROX liquid bleach, FORMULA 409
cleaners, CLOROX CLEAN-UP cleaners, PINE-SOL cleaners, CLOROX toilet bowl
cleaner and TILEX FRESH SHOWER daily shower cleaner; and from significant
product launches, including CLOROX ADVANTAGE liquid bleach and CLOROX FRESHCARE
fabric refresher. Cost of products sold improved in 1999 compared with 1998 due
to the result of numerous cost-savings projects, including line dedication in
the U.S. Home Care and Cleaning business, and additional bottle-making capacity
added during the year.

U.S. SPECIALTY PRODUCTS

2000 vs. 1999: U.S. Specialty Products' 2000 earnings before tax increased 10%
over the prior year due to cost savings contributing to the increase in earnings
despite a decline in net sales. Cost savings were achieved from shifting the
manufacture of certain auto products from contract packers to Company
facilities; eliminating unprofitable product lines from the First Brands
businesses; reductions in inefficient coupon spending partially offset by
increased focus on media spending; and efficiencies gained from integrating
former First Brands businesses. These cost savings were partially offset by
higher resin costs and a charge of $4 million relating to the write down of the
Company's fire logs inventories to their net realizable value. Net sales
decreased due to lower volumes from the former First Brands businesses offset by
the favorable results of eliminating First Brand's inefficient trade-promotion
spending practices. Sales volumes decreased in the auto care, GLAD and cat
litter businesses due to the Company's strategic integration of former First
Brands businesses. Auto care volumes declined due to the elimination of
approximately one-half of the recently acquired STP product line to focus on
more strategic and higher-margin products. Volumes in the GLAD business were
lower than the prior year due to the elimination of non-core, low-margin items.
Cat litter volumes also declined due to reducing the number of cat litter items,
decreased spending on trade-promotion support and changing the pricing
structure. This decline in volume was offset by higher volumes resulting from
the introduction of K C MASTERPIECE marinades and new lines of GLADWARE
disposable container products and gains in shipments of HIDDEN VALLEY Ranch
dressing and KINGSFORD and MATCH LIGHT charcoal products.

1999 vs. 1998: U.S. Specialty Products' 1999 earnings before tax increased by 7%
from 1998. This increase reflects higher net sales partially offset by higher
costs and expenses. The improvement in net sales is attributable to record
volumes achieved from FRESH STEP and FRESH STEP SCOOP cat litters, KINGSFORD
charcoal, HIDDEN VALLEY dressings and K C MASTERPIECE barbecue sauce. This
increase in net sales was partially offset by lower First Brands sales, due
mainly to the negative impact of eliminating First Brands inefficient
trade-promotional practices that had raised net sales in the prior years. Higher
costs and expenses were partly due to the $8 million write off of obsolete
inventory related to the First Brands

B-3

businesses, offset somewhat by lower advertising expenses due to a reduction in
sales promotion spending on First Brands products.

INTERNATIONAL OPERATIONS

2000 vs. 1999: International's 2000 earnings before tax increased by 35% from
1999, due mostly to a 4% increase in net sales as well as achieving cost savings
from the integration of the sales force and distribution network in Latin
America. Net sales reflect an 8% increase in volumes driven primarily by new
product launches in Latin America and the acquisitions of the Bon Bril cleaning
utensil businesses in Latin America and the Astra rubber glove business in
Australia, partly offset by higher promotional spending.

1999 vs. 1998: International's 1999 earnings before tax decreased by 41% from
1998 mostly due to the impact of unfavorable exchange rates and weakened
performance from the Company's international businesses, reflecting economic
slowdowns in those geographic areas.

CORPORATE, INTEREST AND OTHER

2000 vs. 1999: Corporate, Interest and Other's earnings before tax improved by
23% from 1999 to 2000 mostly due to the impact of merger-related charges as
discussed above and a decrease in pension costs resulting from changes in
actuarial assumptions.

1999 vs. 1998: Corporate, Interest and Other's earnings before tax decreased 40%
from 1998 to 1999 mostly due to merger-related charges.

FINANCIAL POSITION AND LIQUIDITY

CASH FLOWS FROM OPERATIONS

Cash provided by operations was $658 million in 2000, $588 million in 1999 and
$417 million in 1998.

The increase in 2000 reflected higher earnings and increased working capital
partially offset by the use of cash for taxes. Working capital changes from 1999
included increases in accounts receivable, inventories and prepaid expenses and
other, and a decrease in accrued restructuring liabilities; these working
capital increases were offset by increases in accounts payable and accrued
liabilities. The 4% increase in accounts receivable over the prior year
corresponded with a 5% increase in net customer sales in the fourth quarter.
Higher inventory levels in 2000 reflected the impact from new product
introductions, and a build of charcoal inventories due to unseasonably cool
weather. Prepaid expenses and other increased mostly due to an Argentine
forward-purchase agreement, which matures in 2001. Increases in accounts payable
and accrued liabilities are partly attributable to higher purchases and accruals
resulting from new product launches.

The increase in 1999 was due principally to decreased working capital
requirements. Working capital changes from 1998 included decreases in accounts
receivable (excluding the impact of $100 million from the Company's trade
receivable financing program which was discontinued in 1999 and is classified as
financing activities) and inventories, and an increase in accrued restructuring
liabilities, which were offset partially by decreases in accounts payable and
accrued liabilities. The increase in accounts receivable was principally due to
the discontinued receivables financing program, offset by improved collections
from the Company's international businesses and the effect of foreign exchange
translation. These cash flow improvements were offset partially by an overall
increase in June 1999 sales experienced by most of the Company's businesses.
Lower inventory levels in 1999 reflect higher June sales, a decline in
promotional activities, tighter management of back-up stocks and the
implementation of a new international logistics strategy. Accrued restructuring
liabilities include accruals for severance, lease and contract cancellation
costs. Accrued liabilities decreased from 1998 primarily due to the timing of
domestic promotional activities and a reduction in accruals associated with the
acquisition of the ARMOR ALL business. Accounts

B-4

payable decreased from 1998 primarily due to lower purchases resulting from
First Brands' decreased June volume.

BORROWING INFORMATION

The Company's overall level of indebtedness (both short-term and long-term debt)
decreased from $1,443 million at June 30, 1999 to $1,363 million at June 30,
2000.

In 2000, the Company reduced certain of its long-term financing agreements,
entered into a $236 million Canadian dollar denominated commercial paper
agreement that is hedged with a forward currency contract for the same amount,
and entered into a 7.38% bank loan totaling $142 million with principal and
interest due in March 2001.

In 1999, the Company terminated certain of its financing agreements that were in
part offset by increases in commercial paper borrowings and a new financing
arrangement completed during the year. In December 1998, the Company redeemed
preference shares totaling $388 million, which were previously classified as
short-term debt. In February 1999, the Company terminated First Brands'
revolving credit facility agreement and related interest rate swap agreements.
Costs associated with terminating the swap agreements were $3 million and were
included in merger-related costs. In June 1999, the Company terminated its
$100 million program to finance receivables. In 1999, the Company entered into a
$200 million Deutsche mark denominated financing arrangement with private
investors. As part of this financing transaction, the Company entered into a
series of swaps with notional amounts, totaling $200 million, to eliminate
foreign currency exposure risk generated by this Deutsche mark denominated
obligation. The swaps effectively convert the Company's 2.9% fixed Deutsche mark
obligation to a floating U.S. dollar rate of 90 day LIBOR less 278 basis points
or an effective rate of approximately 4.1%. Dividends on the preference shares
were classified as interest expense.

ACQUISITIONS

During 2000, the Company invested $120 million in new international businesses.
These acquisitions included the Bon Bril cleaning utensil businesses in
Colombia, Venezuela and Peru, the Agrocom S.A. distribution business in
Argentina, an increase in ownership to 100% in Clorox de Colombia S.A., formerly
Tecnoclor S.A., (previously 72% owned and fully consolidated), and the ASTRA
rubber glove business purchased in Australia.

During 1999, the Company invested $116 million in new businesses, including the
U.S. acquisition of the HANDI WIPES and WASH 'N DRI businesses. International
acquisitions included the MISTOLIN bleach and household cleaner business in
Venezuela, the HOMEKEEPER insecticide business in Korea, the GUMPTION household
cleaner business in Australia, as well as a 12% increase in ownership in the
Company's joint venture in Colombia, Clorox de Colombia S.A.

During 1998, the Company invested $149 million in new international businesses.
These acquisitions included the CLOROSUL bleach business, the SUPER GLOBO bleach
and cleaner business and the X-14 cleaner business, all in Brazil; the ARELA
cleaner business in Chile; three smaller acquisitions in Southeast Asia,
Australia and New Zealand; and an additional investment in Mexico.

COMMON STOCK DIVIDENDS, COMPANY STOCK PURCHASES AND STOCK AUTHORIZATION
INFORMATION

Dividends paid in 2000 were $189 million or $0.80 per share. On July 19, 2000,
the Company announced a 5% increase in the quarterly dividend rate from $0.20
per share to $0.21 per share. On July 20, 1999, the Company's Board of Directors
authorized a 2-for-1 split of its common stock effective August 23, 1999, in the
form of a stock dividend for stockholders of record at the close of business on
July 30, 1999. The Company also made a 2-for-1 stock split on September 2, 1997
to stockholders of record as of July 28,

B-5

1997. All share and per-share information in the accompanying consolidated
financial statements reflects these stock splits.

In September 1999, in response to declines in the Company's stock price in the
first quarter, the Board of Directors authorized a common stock repurchase and
hedging program intended to reduce or eliminate dilution when shares are issued
in accordance with the Company's various stock compensation plans. The Company
had canceled a prior share repurchase and hedging program (previously authorized
in September 1996 by the Board of Directors to offset the dilutive effects of
employee stock option exercises) when it merged with First Brands. The Company
repurchased a total of 3,123,000 shares for $135 million from inception of the
new program through June 30, 2000 and, under the prior program, 800,000 shares
for $33 million in 1999, and 1,694,000 shares for $83 million in 1998.

On September 15, 1999, the Company settled share repurchase agreements and
options contracts realizing cash proceeds of approximately $76 million. On the
same day, the Company entered into two new share repurchase transactions whereby
the Company contracted for future delivery of 2,260,000 shares on September 15,
2002 and 2,260,000 shares on September 15, 2004, each for a strike price of $43
per share. In November 1999, the Company entered into an agreement to purchase
an additional 1,000,000 shares on December 1, 2003 at a price of $46.32 per
share.

On November 17, 1999, the stockholders approved an amendment of the Company's
Certificate of Incorporation to increase the authorized capital of the Company
to consist of 750,000,000 shares of Common Stock and 5,000,000 shares of
Preferred Stock, each with a par value of $1.00 per share.

LIQUIDITY

In 2000, 1999 and 1998, cash flows from operations exceeded cash needs for
capital expenditures, dividends and scheduled debt service. The Company believes
that cash flow from operations, supplemented by financing expected to be
available from external sources, will provide sufficient liquidity for the
foreseeable future. At June 30, 2000, the Company had credit agreements with
available credit totaling $900 million, which expire on dates through
April 2002. These agreements are available for general corporate purposes and
for the support of additional commercial paper. There were no borrowings under
these agreements at June 30, 2000. The credit agreements require maintenance of
a minimum net worth of $704 million. The Company also established an extendable
commercial note program during the year as a supplement to its commercial paper
program. There are no borrowings under these agreements.

The Company has indentures and loan agreements related to the First Brands
businesses. Such agreements contain certain restrictive covenants and
limitations, the most significant of which relates to the Company's right to
incur certain indebtedness and to engage in certain sale and leaseback
transactions. Based on the Company's working capital requirements, the current
availability under its credit agreements, and its ability to generate positive
cash flows from operations, the Company does not believe that such limitations
will have a material effect on the Company's long-term liquidity. The Company
believes that it will have the funds necessary to meet all of its above
described financing requirements and all other fixed obligations. Should the
Company undertake strategic acquisitions, requiring funds in excess of its
internally generated cash flow, it might be required to incur additional debt.
Depending upon conditions in the financial markets, the availability of
acceptable terms, and other factors, the Company may consider the issuance of
debt or other securities to finance acquisitions, to refinance debt or to fund
other activities for general business purposes.

MARKET-SENSITIVE DERIVATIVES AND FINANCIAL INSTRUMENTS

The Company is exposed to the impact of interest rates, foreign currency
fluctuations, commodity prices and changes in the market value of its
investments. The Company has certain restrictions on the usage of derivatives,
including a prohibition of the use of any leveraged instrument. Derivative
contracts are entered into for non-trading purposes with several major credit
worthy institutions, thereby minimizing the risk of

B-6

credit loss. In the normal course of business, the Company employs practices and
procedures to manage its exposure to changes in interest rates, foreign
currencies and commodity prices using a variety of derivative financial and
commodity instruments.

The Company's objective in managing its exposure to changes in interest rates,
foreign currencies and commodity prices is to limit the impact of fluctuations
on earnings, cash flow and, in the case of interest rate changes, to manage
interest rate exposure. To achieve its objectives, the Company primarily uses
swaps and forward and futures contracts to manage its exposures to interest rate
changes in borrowings, foreign currency and commodity risks.

For 2000 and 1999, the Company's exposure to market risk has been estimated
using sensitivity analysis, which is defined as the change in the fair value of
a derivative or financial instrument assuming a hypothetical 10% adverse change
in market rates or prices. The results of the sensitivity analysis are
summarized below. Actual changes in interest rates or market prices may differ
from the hypothetical changes.

The Company has market risk exposure to changing interest rates. Interest rate
risk is managed through the use of a combination of fixed and floating rate
debt. Interest rate swaps may be used to adjust interest rate risk exposures
when appropriate, based on market conditions. These instruments have the effect
of converting fixed rate instruments to floating, or floating to fixed. Changes
in interest rates would result in gains or losses in the market value of the
Company's fixed-rate debt instruments and the Company's interest rate swap
agreements that convert debt instruments from floating to fixed, due to
differences between current market rates and the rates implicit for these
instruments. Based on the results of the sensitivity analysis, at June 30, 2000
and June 30, 1999, the Company's estimated market exposure for interest rates
was $10 million and $13 million, respectively.

The Company seeks to minimize the impact of foreign currency fluctuations by
hedging transactional exposures with foreign currency forward contracts. In
addition, the Company has hedged certain net investments with similar
instruments. The Company's foreign currency transactional exposures exist
primarily with the Canadian dollar, Australian dollar and Japanese yen. The
Company has certain positions in the Argentine peso, which are not accorded
hedge accounting treatment. At June 30, 2000 and June 30, 1999, there were no
material foreign currency transactional exposures that were not hedged. The
foreign exchange sensitivity analysis includes forward contracts and other
financial instruments affected by foreign exchange risk. Based on the
hypothetical change in foreign currency exchange rates, the net unrealized
losses at June 30, 2000 and 1999 would be $23 million and $4 million,
respectively.

Commodity futures and swap contracts are used to manage cost exposures on
certain raw material purchases resulting in relatively stable costs for these
commodities. The commodity price sensitivity analysis includes commodity futures
and swap contracts affected by commodity price risk. Based on the results of the
sensitivity analysis, at June 30, 2000 and June 30, 1999, the Company's
estimated market exposure for commodity prices was $14 million and $17 million,
respectively.

YEAR 2000 COMPLIANCE

In 1997, the Company established a comprehensive corporate-wide program to
address the Year 2000 or "Y2K" problem. This effort encompassed software,
hardware, electronic data interchange, networks, personal computers,
manufacturing and other facilities, embedded chips, century certification,
supplier and customer readiness, contingency planning and domestic and
international operations. Following the Company's January 29, 1999 merger with
First Brands, the Company incorporated First Brands and its subsidiaries into
the Company's Y2K compliance program.

As of December 31, 1999, the Company had completed all of its Y2K compliance
efforts on all of its critical domestic and international business systems, its
critical plant floor equipment, instrumentation and facilities, and its third
party assessment for all of its operations. The Company developed written

B-7

contingency plans for its critical operations and third party relationships, but
did not implement any of these plans because the Company did not experience any
material Y2K related issues with the turnover of the year to 2000.

Y2K costs were expensed as incurred and funded through operating cash flows.
Through the fiscal year ended June 30, 2000, the Company has expensed
incremental remediation costs of $20.5 million and accelerated strategic upgrade
costs of $20.5 million. The Company expensed $4 million in fiscal year 2000 on
Y2K remediation issues. The Company did not defer any critical information
technology projects because of its Year 2000 program efforts, which were
primarily addressed through a joint team of the Company's business and
information technology resources.

ENVIRONMENTAL MATTERS

The Company is committed to an ongoing program of comprehensive, long-term
environmental assessment of its facilities. This program is implemented by the
Company's Department of Health, Safety and Environment with guidance from legal
counsel. During each facility assessment, compliance with applicable
environmental laws and regulations is evaluated and the facility is reviewed in
an effort to identify possible future environmental liabilities. The Company
believes that there are no potential future environmental liabilities that will
have a material adverse effect on its financial position or future operating
results, although no assurance can be given with respect to the ultimate outcome
of any such matters. This premise is based on the probable future costs of
environmental liabilities without an offset for expected insurance recoveries or
discounting for present value.

IMPACT OF NEW ACCOUNTING STANDARDS

Effective July 1, 2000, the Company adopted SFAS No. 133 "Accounting for
Derivative Instruments and Hedging Activities," as amended by SFAS No. 138,
"Accounting for Certain Derivative Instruments and Certain Hedging Activities."
SFAS No. 133, as amended, establishes accounting and reporting standards for
derivative instruments, including certain derivative instruments embedded in
other contracts, and for hedging activities. The statement requires that an
entity recognize all derivatives as either assets or liabilities in the
statement of financial position and measure those instruments at fair value. The
Company estimates that the transition adjustment to implement this new standard
will be a reduction of net earnings of $2 million (net of tax of $1 million) and
an increase in other comprehensive income of $10 million (net of tax of $7
million). These adjustments will be recognized as of July 1, 2000 as a
cumulative effect of a change in accounting principle. The ongoing effects will
depend on future market conditions and the Company's hedging activities.

In December 1999, the Securities and Exchange Commission ("SEC") issued SEC
Staff Accounting Bulletin ("SAB") No. 101, "Revenue Recognition in Financial
Statements," as amended by SAB No. 101A, which delayed the implementation date
of SAB No. 101 for companies with fiscal years beginning between December 16,
1999 and March 15, 2000. Since the issuance of SAB No. 101 and SAB No. 101A, the
SEC issued SAB No. 101B, which delayed implementation until no later than the
fourth fiscal quarter of fiscal years beginning after December 15, 1999. SAB
No. 101 summarizes the SEC's views in applying generally accepted accounting
principles to revenue recognition in financial statements. Also, in July 2000,
the Financial Accounting Standards Board ("FASB") reached consensus and issued
Emerging Issues Task Force ("EITF") No. 00-14, "Accounting for Coupons, Rebates,
and Discounts," with the same implementation date as SAB No. 101. EITF
No. 00-14 addresses both the accounting for sales subject to rebates and revenue
sharing arrangements as well as coupons and discounts and the income statement
classification of rebates and other discounts. In March 2000, the FASB issued
guidance on stock compensation issues in the form of FASB Interpretation
No. 44, "Accounting for Certain Transactions involving Stock Compensation, an
Interpretation of APB Opinion No. 25." The Interpretation clarifies the
application of APB Opinion No. 25 for certain issues. The Interpretation is
effective beginning July 1, 2000. The Company is currently evaluating the impact
of SAB No. 101, as amended, EITF No. 00-14 and Interpretation No. 44 on the

B-8

Company's consolidated financial position and results of operations, but has not
concluded as to the significance of the potential impact, if any, when these new
standards are adopted.

CAUTIONARY STATEMENT

Except for historical information, matters discussed above and in the financial
statements and footnotes, including statements about future plans, objectives,
expectations, growth or profitability, are forward-looking statements based on
management's estimates, assumptions and projections. These forward-looking
statements are subject to risks and uncertainties, and actual results could
differ materially from those discussed in this Appendix B to the 2000 Proxy
Statement of the Company. Important factors that could affect performance and
cause results to differ materially from management's expectations are described
in "Forward-Looking Statements and Risk Factors" in the Company's Annual Report
on Form 10-K for the year ending June 30, 2000, which is expected to be filed
with the SEC on or about September 28, 2000, and in subsequent SEC filings.
Those factors include, but are not limited to, marketplace conditions and
events, the Company's costs, risks inherent in litigation and international
operations, the success of new products, the integration of acquisitions and
mergers, and environmental, regulatory and intellectual property matters. These
forward-looking statements speak only as of the date of this document.

B-9

FINANCIAL HIGHLIGHTS
THE CLOROX COMPANY

YEARS ENDED JUNE 30 2000 1999 % CHANGE
- ------------------------------------------------------------------------------------------
IN MILLIONS, EXCEPT SHARE AND PER-SHARE AMOUNTS.

Net Sales................................................... $ 4,083 $ 4,003 2%
Net Earnings................................................ $ 394 $ 246 60%
Stockholders' Equity........................................ $ 1,794 $ 1,570 14%
Per Common Share
Net Earnings
Basic................................................... $ 1.67 $ 1.05 59%
Diluted................................................. $ 1.64 $ 1.03 59%
Dividends................................................. $ 0.80 $ 0.71 13%
Stockholders' Equity...................................... $ 7.62 $ 6.67 14%
Weighted Average Shares Outstanding (in thousands)
Basic..................................................... 236,108 235,364 0%
Diluted................................................... 239,614 240,002 0%

B-10

CONSOLIDATED STATEMENTS OF EARNINGS
THE CLOROX COMPANY

YEARS ENDED JUNE 30 2000 1999 1998
- --------------------------------------------------------------------------------------------
IN MILLIONS, EXCEPT SHARE AND PER-SHARE AMOUNTS.

Net Sales................................................... $ 4,083 $ 4,003 $ 3,898
------- ------- -------
Costs and Expenses
Cost of products sold..................................... 2,250 2,181 2,124
Selling and administration................................ 525 554 548
Advertising............................................... 465 474 491
Research and development.................................. 63 63 62
Merger, restructuring and asset impairment................ 36 180 3
Interest expense.......................................... 98 97 104
Other expense -- Net...................................... 24 24 10
------- ------- -------
Total Costs and Expenses................................ 3,461 3,573 3,342
------- ------- -------
Earnings before income taxes and cumulative effect of change
in accounting principle................................... 622 430 556
Income Taxes................................................ 228 184 206
------- ------- -------
Earnings before cumulative effect of change in accounting
principle................................................. 394 246 350
Cumulative effect of change in accounting principle......... - - (7)
------- ------- -------
Net Earnings................................................ $ 394 $ 246 $ 343
======= ======= =======
Earnings per Common Share
Basic
Earnings before cumulative effect of change in
accounting principle.................................. $ 1.67 $ 1.05 $ 1.49
Cumulative effect of change in accounting principle..... - - (.03)
------- ------- -------
Net Earnings.............................................. $ 1.67 $ 1.05 $ 1.46
======= ======= =======
Diluted
Earnings before cumulative effect of change in
accounting principle.................................. $ 1.64 $ 1.03 $ 1.46
Cumulative effect of change in accounting principle..... - - (.03)
------- ------- -------
Net Earnings.............................................. $ 1.64 $ 1.03 $ 1.43
======= ======= =======
Weighted Average Shares Outstanding (in thousands)
Basic..................................................... 236,108 235,364 234,666
Diluted................................................... 239,614 240,002 239,540

See Notes to Consolidated Financial Statements.

B-11

CONSOLIDATED BALANCE SHEETS

THE CLOROX COMPANY

YEARS ENDED JUNE 30 2000 1999
- --------------------------------------------------------------------------------
IN MILLIONS, EXCEPT SHARE AND PER-SHARE AMOUNTS.

ASSETS

Current Assets
Cash and short-term investments........................... $ 245 $ 132
Receivables -- Net........................................ 633 610
Inventories............................................... 376 319
Prepaid expenses and other................................ 175 29
Deferred income taxes..................................... 25 26
------ ------
Total current assets.................................... 1,454 1,116
------ ------
Property, Plant and Equipment -- Net........................ 1,079 1,054
------ ------
Brands, Trademarks, Patents and Other Intangibles -- Net.... 1,536 1,497
------ ------
Investments in Affiliates................................... 110 104
------ ------
Other Assets................................................ 174 361
------ ------
Total....................................................... $4,353 $4,132
====== ======

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
Accounts payable.......................................... $ 319 $ 206
Accrued liabilities....................................... 395 350
Accrued restructuring..................................... 16 23
Short-term debt and notes payable......................... 768 734
Income taxes payable...................................... 38 48
Current maturities of long-term debt...................... 5 7
------ ------
Total current liabilities............................... 1,541 1,368
------ ------
Long-term Debt.............................................. 590 702
------ ------
Other Obligations........................................... 204 255
------ ------
Deferred Income Taxes....................................... 224 237
------ ------
Stockholders' Equity
Common stock, $1.00 par value, 750,000,000 shares
authorized, 249,826,934 shares issued and 235,361,130
shares and 235,310,754 shares outstanding at June 30,
2000 and 1999, respectively............................. 250 250
Additional paid-in capital................................ 127 50
Retained earnings......................................... 2,068 1,842
Treasury shares, at cost, 14,465,804 shares and 14,516,180
shares at June 30, 2000 and 1999, respectively.......... (451) (392)
Accumulated other comprehensive net losses................ (183) (160)
Other..................................................... (17) (20)
------ ------
Stockholders' equity.................................... 1,794 1,570
------ ------
Total....................................................... $4,353 $4,132
====== ======

See Notes to Consolidated Financial Statements.

B-12

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
THE CLOROX COMPANY

ACCUMULATED
ADDITIONAL OTHER TOTAL
COMMON PAID-IN RETAINED TREASURY COMPREHENSIVE COMPREHENSIVE
STOCK CAPITAL EARNINGS SHARES NET LOSSES OTHER TOTAL INCOME
- ---------------------------------------------------------------------------------------------------------------------------------
IN MILLIONS, EXCEPT PER-SHARE AMOUNTS.

Balance, June 30, 1997............... $249 $ - $1,542 $(289) $ (60) $(12) $1,430

Comprehensive income
Net earnings....................... 343 343 $343
Translation adjustments............ (57) (57) (57)
Minimum pension liability
adjustments...................... 1 1 1
----
Total comprehensive income........... $287
====

Dividends ($.63 per share)......... (147) (147)
Employee stock plans and other..... 21 10 35 1 67
Clorox treasury stock acquired and
related premiums................. (83) (83)
First Brands treasury stock
acquired......................... (21) (5) (26)
Share repurchase obligations....... (55) (55)
---- ---- ------ ----- ----- ---- ------
Balance, June 30, 1998............... 249 -- 1,743 (392) (116) (11) 1,473

Comprehensive income
Net earnings....................... 246 246 $246
Translation adjustments............ (43) (43) (43)
Minimum pension liability
adjustments...................... (1) (1) (1)
----
Total comprehensive income........... $202
====

Dividends ($.71 per share)......... (162) (162)
Employee stock plans and other..... 1 50 15 33 (9) 90
Clorox treasury stock acquired..... (33) (33)
---- ---- ------ ----- ----- ---- ------
Balance, June 30, 1999............... 250 50 1,842 (392) (160) (20) 1,570

Comprehensive income
Net earnings....................... 394 394 $394
Translation adjustments............ (23) (23) (23)
----
Total comprehensive income........... $371
====

Dividends ($.80 per share)......... (189) (189)
Employee stock plans and other..... 13 21 21 3 58
Clorox treasury stock acquired and
related premiums................. (12) (135) (147)
Settlement of share repurchase
obligations and option
contracts........................ 76 55 131
---- ---- ------ ----- ----- ---- ------
Balance, June 30, 2000............... $250 $127 $2,068 $(451) $(183) $(17) $1,794
==== ==== ====== ===== ===== ==== ======

See Notes to Consolidated Financial Statements.

B-13

CONSOLIDATED STATEMENTS OF CASH FLOWS
THE CLOROX COMPANY

YEARS ENDED JUNE 30 2000 1999 1998
- -----------------------------------------------------------------------------------
IN MILLIONS.

Operations:
Net earnings.............................................. $ 394 $ 246 $ 343
Adjustments to reconcile to net cash provided by
operations:
Provision for inventory write-downs and asset
impairment............................................ 12 99 -
Cumulative effect of change in accounting principle..... - - 7
Depreciation and amortization........................... 201 202 182
Deferred income tax..................................... (16) (29) 52
Other................................................... 11 (14) (1)
Changes in (excluding effects of businesses acquired):
Accounts receivable................................... (19) 24 (76)
Inventories........................................... (55) 40 (47)
Prepaid expenses and other............................ (3) 2 1
Accounts payable...................................... 109 (19) 21
Accrued liabilities................................... 42 (9) (67)
Accrued restructuring................................. (7) 23 3
Income taxes payable.................................. (11) 23 (1)
----- ----- -----
Net cash provided by operations....................... 658 588 417
----- ----- -----
Investing Activities:
Purchases of property, plant and equipment................ (158) (176) (190)
Businesses acquired....................................... (120) (116) (149)
Proceeds from disposals of property, plant and
equipment............................................... 3 16 19
Other..................................................... 15 (37) (81)
----- ----- -----
Net cash used for investing........................... (260) (313) (401)
----- ----- -----
Financing Activities:
Short-term debt and notes payable borrowings (repayments)
-- Net.................................................. 34 (232) 221
Long-term debt and other borrowings....................... 5 205 3
Long-term debt and other repayments....................... (117) (16) (66)
First Brands receivables financing program -- Net......... - (100) 15
Cash dividends............................................ (189) (162) (147)
Treasury stock purchased and related premiums............. (135) (33) (109)
Settlement of share repurchase and option contracts....... 76 - -
Issuance of common stock for employee stock plans and
other................................................... 41 93 64
----- ----- -----
Net cash used for financing........................... (285) (245) (19)
----- ----- -----
Effect on cash of exchange rate changes..................... - - (4)
Net increase (decrease) in cash and short-term
investments............................................... 113 30 (7)
Cash and short-term investments:
Beginning of year......................................... 132 102 109
----- ----- -----
End of year............................................... $ 245 $ 132 $ 102
===== ===== =====
Supplemental Disclosure:
Cash paid for:
Interest (net of amounts capitalized)................... $ 92 $ 98 $ 105
Income taxes............................................ 166 85 113
Non-cash transactions:
Liabilities assumed with businesses purchased........... $ 9 $ - $ 28
Share repurchase and other obligations.................. 55 - 79

See Notes to Consolidated Financial Statements.

B-14

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

1. SIGNIFICANT ACCOUNTING POLICIES

NATURE OF OPERATIONS AND PRINCIPLES OF CONSOLIDATION

The Company is principally engaged in the production and marketing of nondurable
consumer products through grocery stores, mass merchandisers and other retail
outlets. The consolidated financial statements include the statements of the
Company and its majority-owned and controlled subsidiaries. Minority investments
in foreign entities are accounted for under the equity method, the most
significant of which is a 20% equity investment in Henkel Iberica, S.A. of
Spain. All significant intercompany transactions and accounts are eliminated in
consolidation.

MERGER WITH FIRST BRANDS CORPORATION ("FIRST BRANDS")

The Company's results reflect the January 29, 1999 merger with First Brands
Corporation ("First Brands") which was accounted for as a pooling of interests.
All historical financial information has been restated to include First Brands.

Pursuant to the merger agreement, First Brands stockholders obtained the right
to receive .349 of a share of the Company's common stock in exchange for each
share of First Brands common stock, with cash paid in lieu of fractional shares.
Pursuant to the merger, 40.3 million shares of First Brands common stock were
converted into 28.2 million shares of the Company's common stock. In addition,
options to acquire 1.8 million shares of First Brands' common stock were
converted to 1.2 million options to acquire shares of the Company's common
stock. In connection with the merger, the Company also assumed approximately
$435 of First Brands debt.

Additional information pertaining to merger costs is presented in Note 2.

STOCK-SPLIT

On July 20, 1999, the Company's Board of Directors authorized a 2-for-1 split of
its common stock, effective August 23, 1999, in the form of a stock dividend for
stockholders of record at the close of business on July 30, 1999. On July 15,
1997, the Company's Board of Directors authorized a 2-for-1 split of its common
stock, effective September 2, 1997, in the form of a stock dividend for
stockholders of record at the close of business on July 28, 1997. All share and
per-share amounts in the accompanying consolidated financial statements have
been restated to give effect to these stock splits.

ACCOUNTING ESTIMATES

The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect reported
amounts and related disclosures. Actual results could differ from estimates and
assumptions made.

SHORT-TERM INVESTMENTS

Short-term investments consist of money market and other high quality
instruments with an initial maturity of three months or less. Such investments
are stated at cost, which approximates market value.

B-15

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

1. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
INVENTORIES

Inventories are stated at the lower of cost or market. Cost for the majority of
the domestic inventories, excluding First Brands businesses, is determined on
the last-in, first-out (LIFO) method. Cost for other inventories, including
First Brands businesses, is determined on the first-in, first-out (FIFO) method.

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment are stated at cost. Depreciation is calculated by
the straight-line method over estimated useful lives ranging from 20-30 years
for improvements, 20-40 years for buildings and 3-15 years for machinery and
equipment. Carrying values are reviewed periodically and a determination of
impairment is made based on estimates of future cash flows, undiscounted and
without interest charges.

BRANDS, TRADEMARKS, PATENTS AND OTHER INTANGIBLES

Brands, trademarks, patents and other intangible assets arising from
transactions after October 30, 1970 are amortized over their estimated useful
lives not to exceed 40 years. Carrying values are reviewed periodically, and a
determination of impairment is made based on estimates of future cash flows,
undiscounted and without interest charges.

FORWARD-PURCHASE FINANCING AGREEMENTS

In connection with the financing of an acquisition in Argentina in 1996 and the
acquisition of the Brita water systems business in Canada in 1995, the Company
entered into forward-purchase agreements with third parties whereby the Company
has purchased preferred stock of certain of its foreign subsidiaries for future
delivery from third parties who have the right to acquire this preferred stock
according to the terms of certain subscription agreements. In June 2000, the
Brita forward-purchase agreement matured and the third party acquired the
subsidiary preferred stock. The Argentina forward-purchase agreement matures in
2001 and is included in prepaid expenses and other assets. The forward purchases
of the preferred stock are accreted to redemption amounts on a straight-line
basis over five years and the amount of accretion is included in other income.
If the third parties fail to acquire the subsidiary preferred stock at maturity
of the subscription agreements, the accreted amounts of the forward-purchase
agreements will be due to the Company.

ADVERTISING

The Company expenses advertising costs as incurred, although costs incurred
during interim periods are generally expensed ratably in relation to revenues.

INCOME TAXES

The Company uses the asset and liability method to account for income taxes,
including recognition of deferred tax assets and liabilities for the anticipated
future tax consequences attributable to differences between financial statement
amounts and their respective tax bases (see Note 15).

B-16

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

1. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
FOREIGN CURRENCY TRANSLATION

Local currencies are the functional currencies for most of the Company's foreign
operations. Assets and liabilities are translated using the exchange rates in
effect at the balance sheet date. Income and expenses are translated at the
average exchange rates during the year. Translation gains and losses and the
effects of exchange rate changes on transactions designated as hedges of net
foreign investments are reported in accumulated other comprehensive income or
loss in stockholders' equity. Transaction and foreign currency translation gains
and losses where the U.S. dollar is the functional currency are included in
other income.

EARNINGS PER COMMON SHARE

Basic earnings per share is computed by dividing net earnings by the weighted
average number of common shares outstanding each period. Diluted earnings per
share are computed by dividing net earnings by the diluted weighted average
number of common shares outstanding during the period. Diluted earnings per
share reflects the potential dilution from common shares issuable through stock
options, restricted stock and performance unit grants.

DERIVATIVE INSTRUMENTS

The use of derivative instruments, principally swap, forward and option
contracts, is limited to non-trading purposes and includes management of
interest rate movements, foreign currency exposure and commodity exposure.
Through June 30, 2000, such derivatives were not recognized as assets or
liabilities in the consolidated balance sheet. Interest rate swap agreements are
accounted for using the settlement basis of accounting. As such, no gains or
losses are recorded for movements in the swaps' values during the term of the
agreements. Foreign currency forward contracts are used to hedge certain
short-term and long-term instruments and to hedge the impact of exchange rate
fluctuations resulting from anticipated inventory purchases and intercompany
transactions. Gains or losses on hedges of existing assets are included in the
carrying amounts and are recognized in earnings when those assets are
liquidated. Gains or losses arising from hedges of firm commitments and
anticipated transactions are recognized in earnings or as an adjustment of
carrying amounts when the hedged transaction occurs. The Company also holds
Argentine foreign currency contracts that are not accorded hedge accounting
treatment. These contracts are accounted for by adjusting the carrying amount of
the contract to market and recognizing any gain or loss in other income or
expense.

STOCK-BASED COMPENSATION

The Company continues to account for stock-based compensation using the
intrinsic value method prescribed in Accounting Principles Board ("APB") Opinion
No. 25, "Accounting for Stock Issued to Employees." Compensation cost for stock
options, if any, is measured as the excess of the quoted market price of the
Company's stock at the date of grant over the amount an employee must pay to
acquire the stock. Restricted stock awards are recorded as compensation cost
over the requisite vesting periods based on the market value on the date of
grant. Compensation cost for shares issued under performance share plans is
recorded based upon the current market value of the Company's stock at the end
of each period.

Statement of Financial Accounting Standards ("SFAS") No. 123, "Accounting for
Stock-Based Compensation," established accounting and disclosure requirements
using a fair-value based method of accounting

B-17

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

1. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
for stock-based employee compensation plans. The Company has elected to retain
its current method of accounting as described above and has adopted the
disclosure requirements of SFAS No. 123. (See Note 12).

IMPACT OF NEW ACCOUNTING STANDARDS

Effective July 1, 2000, the Company adopted SFAS No. 133 "Accounting for
Derivative Instruments and Hedging Activities," as amended by SFAS No. 138,
"Accounting for Certain Derivative Instruments and Certain Hedging Activities."
SFAS No. 133, as amended, establishes accounting and reporting standards for
derivative instruments, including certain derivative instruments embedded in
other contracts, and for hedging activities. The statement requires that an
entity recognize all derivatives as either assets or liabilities in the
statement of financial position and measure those instruments at fair value. The
Company estimates that the transition adjustment to implement this new standard
will be a reduction of net earnings of $2 (net of tax of $1) and an increase in
other comprehensive income of $10 (net of tax of $7). These adjustments will be
recognized as of July 1, 2000 as a cumulative effect of a change in accounting
principle. The ongoing effects will depend on future market conditions and the
Company's hedging activities.

In December 1999, the Securities and Exchange Commission ("SEC") issued SEC
Staff Accounting Bulletin ("SAB") No. 101, "Revenue Recognition in Financial
Statements," as amended by SAB No. 101A, which delayed the implementation date
of SAB No. 101 for companies with fiscal years beginning between December 16,
1999 and March 15, 2000. Since the issuance of SAB No. 101 and SAB No. 101A, the
SEC issued SAB No. 101B, which delayed implementation until no later than the
fourth fiscal quarter of fiscal years beginning after December 15, 1999. SAB
No. 101 summarizes the SEC's views in applying generally accepted accounting
principles to revenue recognition in financial statements. Also, in July 2000,
the Financial Accounting Standards Board ("FASB") reached consensus and issued
Emerging Issues Task Force ("EITF") No. 00-14, "Accounting for Coupons, Rebates,
and Discounts," with the same implementation date as SAB No. 101. EITF
No. 00-14 addresses both the accounting for sales subject to rebates and revenue
sharing arrangements as well as coupons and discounts and the income statement
classification of rebates and other discounts. In March 2000, the FASB issued
guidance on stock compensation issues in the form of FASB Interpretation
No. 44, "Accounting for Certain Transactions involving Stock Compensation, an
Interpretation of APB Opinion No. 25." The Interpretation clarifies the
application of APB Opinion No. 25 for certain issues. The Interpretation is
effective beginning July 1, 2000. The Company is currently evaluating the
impacts of SAB No. 101, as amended, EITF No. 00-14 and Interpretation No. 44 on
the Company's consolidated financial position and results of operations, but has
not concluded as to the significance of the potential impact, if any, when these
new standards are adopted.

RECLASSIFICATIONS

Certain reclassifications have been made to the prior years' financial
statements to conform to the current year's presentation. These include the
reclassification of delivery costs to cost of products sold, previously reported
as part of selling, delivery and administration expense, to conform to the
current year's presentation.

B-18

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

1. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
ACCOUNTING CHANGE

In 1998, First Brands changed its accounting policy for costs associated with
the business process re-engineering activities to expense such costs as incurred
in accordance with the FASB Emerging Issues Task Force Issue No. 97-13.
Previously capitalized costs of $11 ($7 after taxes or $0.03 per diluted share)
were charged to operations in 1998 as cumulative effect of change in accounting
principle.

2. MERGER, RESTRUCTURING AND ASSET IMPAIRMENT

Merger, restructuring and asset impairment were $36, $180 and $3 in 2000, 1999
and 1998, respectively. The $36 of merger costs in 2000 includes $23 of merger,
restructuring and asset impairment incurred in connection with the merger of
First Brands, $11 of restructuring and asset impairment related to the
restructuring of the Company's Asia operations recognized in the fourth quarter
of 2000, and $2 of asset impairment losses recognized for the write-down of
property, plant and equipment related to the Company's fire logs business. In
1999, the Company recorded $180 of merger costs that included $156 of merger,
restructuring and asset impairment incurred in connection with the First Brands
merger, and $24 for impairment and write-down of certain insecticide brands and
certain international assets. In 1998, First Brands recorded $3 of restructuring
charges for initiatives aimed at streamlining certain operating and
administrative functions.

Merger, restructuring and asset impairment costs were recognized during 2000 and
1999 in connection with the First Brands merger, Asia restructuring and other
asset impairments. Details of these costs through June 30, 2000 are as follows:

TOTAL MERGER ASSET
MERGER RESTRUCTURING AND RESTRUCTURING IMPAIRMENT TOTAL
-------- ------------- ----------------- ---------- --------

Expense for the year:
June 30, 1999......................... $36 $53 $ 89 $91 $180
June 30, 2000......................... 17 11 28 8 36
--- --- ---- --- ----
Total incurred through June 30, 2000.... 53 64 117 $99 $216
=== ====
Total paid through June 30, 2000........ (48) (53) (101)
--- --- ----
$ 5 $11
=== ===

Accrued Restructuring as of June 30,
2000.................................. $ 16
====

First Brand restructuring activities primarily related to the elimination of
redundancies and the consolidation of administration and distribution functions,
the reduction in employee headcount, primarily at the First Brands' headquarters
location in Danbury, Connecticut and at sales offices, and the termination of
lease and other contractual obligations. All merger, restructuring and asset
impairment costs related to the First Brands merger have been recognized through
June 30, 2000.

The Company is restructuring its Asia operations by moving to third-party
distributors in various Asian countries. Asia restructuring activities include
the reduction in employee headcount, the termination of lease obligations,
charges for professional services and the write off of certain assets.

B-19

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

3. ACQUISITIONS

Acquisitions made in years 2000, 1999 and 1998 were accounted for by the
purchase method and are summarized below.

International acquisitions in 2000 totaled $120. These acquisitions included the
Bon Bril cleaning utensil business in Colombia, Venezuela and Peru, the Agrocom
S.A. distribution business in Argentina, an increase in ownership to 100% in
Clorox de Colombia S.A., formerly Tecnoclor, S.A., (previously 72% owned and
fully consolidated), and the ASTRA rubber glove business purchased in Australia.
Net assets, acquired at fair value, included net working capital assets of $6,
property, plant and equipment of $12, and brands, trademarks and other
intangibles of $94 to be amortized over estimated lives not to exceed 40 years.
In addition, approximately $8 was paid to acquire minority interests in Clorox
de Colombia S.A.

Acquisitions in 1999 totaled $116. These acquisitions included the domestic
purchase of the HANDI WIPES and WASH 'N DRI businesses and the international
purchases of the MISTOLIN bleach and household cleaner business in Venezuela,
the HOMEKEEPER insecticide business in Korea, the GUMPTION household cleaner
business in Australia, as well as a 12% increase in ownership in the Company's
joint venture in Colombia, Clorox de Colombia S.A. Approximately $105 of the
acquisition cost has been allocated to brands, trademarks and other intangibles
to be amortized over estimated lives not to exceed 40 years, with the remainder
of $11 allocated to the fair value of other assets acquired.

International acquisitions in 1998 totaled $149 and included the CLOROSUL bleach
business, the SUPER GLOBO bleach and cleaner business and the X-14 cleaner
business, all in Brazil, the ARELA cleaner business in Chile, three smaller
acquisitions in Southeast Asia, Australia and New Zealand, and an additional
investment in Mexico. Approximately $144 of the acquisition cost has been
allocated to brands, trademarks and other intangibles to be amortized over
estimated lives not to exceed 40 years, with the remainder of $34 allocated to
the fair value of other assets acquired, net of liabilities of $29 assumed.

Operating results of acquired businesses are included in the consolidated net
earnings from the date of acquisition. All acquisitions were funded from cash
provided by operations, long-term debt or commercial paper. In any year
presented, the operating results of businesses acquired were not significant to
the consolidated results.

4. TRADE RECEIVABLE FINANCING PROGRAM

During the fourth quarter of 1999, the Company terminated First Brands' program
to sell up to $100 in fractional ownership interest in a defined pool of
eligible trade accounts receivable. Accounts receivable in the accompanying
consolidated balance sheets were reported net of amounts sold pursuant to this
program and related costs were charged to earnings as interest expense when the
receivables were sold. The effective interest rate for this program was
approximately 5.5% in 1999 and 5.9% in 1998.

5. INVENTORIES

The major classes are:

2000 1999
-------- --------

Finished goods and work in process.......................... $250 $220
Raw materials and supplies.................................. 126 99
---- ----
Total....................................................... $376 $319
==== ====

B-20

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

5. INVENTORIES (CONTINUED)
Had the cost of LIFO inventories been determined using the FIFO method,
inventory amounts would have been higher by approximately $10 at June 30, 2000
and $12 at June 30, 1999. The LIFO method was used to value approximately 42% of
inventory at June 30, 2000 and 38% at June 30, 1999. Liquidation of LIFO layers
was not material at June 30, 2000 and June 30, 1999.

Inventory of certain First Brands products were written down to their net
realizable value, and cost of products sold includes a corresponding charge of
$4 for the year ended June 30, 2000 and $8 for the year ended June 30, 1999.

6. PROPERTY, PLANT AND EQUIPMENT -- NET

The major classes are:

2000 1999
-------- --------

Land and improvements....................................... $ 91 $ 91
Buildings................................................... 418 391
Machinery and equipment..................................... 1,313 1,198
Construction in progress and other.......................... 135 161
------ ------
Total....................................................... 1,957 1,841
Less accumulated depreciation............................... 878 787
------ ------
Net......................................................... $1,079 $1,054
====== ======

Depreciation expense was $121 in 2000, $115 in 1999 and $109 in 1998.

7. BRANDS, TRADEMARKS, PATENTS AND OTHER INTANGIBLES -- NET

The major classes are:

2000 1999
-------- --------

Brands and trademarks....................................... $1,771 $1,681
Patents and other intangibles............................... 320 316
------ ------
Total....................................................... 2,091 1,997
Less accumulated amortization............................... 555 500
------ ------
Net......................................................... $1,536 $1,497
====== ======

At June 30, 2000 and 1999, respectively, brands and trademarks totaling $1,484
and $1,480 are amortized over 40 years, $39 and $27 are amortized over 30 years,
$202 and $132 are amortized over 20 years and $4 (none in 1999) are amortized
over 10 years. Amounts totaling $42 relating to transactions prior to
October 31, 1970 are not amortized. Patents and other intangibles are amortized
over lives ranging from 2 to 20 years.

8. ACCRUED LIABILITIES

Advertising costs included in accrued liabilities at June 30, 2000 and 1999 were
$138 and $157, respectively.

B-21

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

9. DEBT

Short-term debt and notes payable include:

2000 1999
-------- --------

Commercial paper............................................ $613 $726
Notes payable and other..................................... 155 8
---- ----
Total....................................................... $768 $734
==== ====

In 2000, the Company issued $236 of Canadian dollar denominated commercial paper
that is hedged with a forward currency contract for the same amount. Also in
2000, the Company entered into a 7.38% bank loan totaling $142 with principal
and interest due in March 2001.

In 1999, the Company redeemed preference shares totaling $388, which had been
classified as other short-term debt. These shares were issued in 1998 and 1997
when the Company entered into sterling denominated agreements for the issuance
of redeemable subsidiary preference shares to private investors. The Company
also terminated related swap agreements that covered both foreign currency and
interest rate exposures. Costs to terminate the swap agreements were
approximately $7 and are included in other expense, net. Dividend payments on
the preference shares were classified as interest expense.

Long-term debt includes:

2000 1999
-------- --------

8.8% Non-callable notes due August 2001(a).................. $200 $200
Preferred interest transferable securities due July 2003
with a preferred dividend rate of 2.9%(b)................. 200 200
7 1/4% senior notes due 2007(c)............................. 150 150
Bank loans due through March 2007, at a rate of 5.9% in 2000
and rates ranging from 5.9% to 7.9% in 1998............... 13 98
Australian and New Zealand credit facility, $32 seven-year
term, expiring March 2004, interest at local "Bill Rate"
plus .7%(d)............................................... 10 35
Other....................................................... 17 19
---- ----
Total....................................................... $590 $702
==== ====

- ---------

(a) At June 30, 2000 and June 30, 1999, the Company had interest rate swaps that
converted $50 of the 8.8% note from a fixed to a floating rate resulting in
effective borrowing rates of 8.6% in 2000, 8.1% in 1999 and 8.3% in 1998.

(b) In 1999, the Company entered into a Deutsche mark denominated financing
arrangement with private investors. The Company also entered into a series
of swaps with notional amounts totaling $200 to eliminate foreign currency
exposure risks. The swaps effectively convert the Company's 2.9% fixed
Deutsche mark obligation to a floating U.S. dollar rate of 90 day LIBOR less
278 basis points (effective rate of approximately 4.1%). Dividend payments
on preference shares are classified as interest expense.

B-22

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

9. DEBT (CONTINUED)
(c) The 7 1/4% Note Indenture contains certain restrictive covenants and
limitations, the most significant of which relates to the Company's right to
incur debt and to engage in certain sale and leaseback transactions.

(d) The seven-year $32 Australian and New Zealand credit facility is composed of
(1) amounts used to acquire Clorox Australia Pty. Limited, formerly
NationalPak Pty. Limited, and Clorox New Zealand Limited, formerly
NationalPak New Zealand Limited (the acquisition borrowing for New Zealand
was repaid in 2000) and (2) amounts used for working capital needs. There
are fixed periodic payments associated with the acquisition borrowing. The
working capital borrowing can be drawn on and repaid at Clorox Australia
Pty. Limited and Clorox New Zealand Limited's discretion. The facility is
secured by the accounts receivable, inventory and fixed assets of Clorox
Australia Pty. Limited and Clorox New Zealand Limited (approximately $10 at
June 30, 2000). At June 30, 2000 and June 30, 1999, the Company had interest
rate swaps totaling $9 and $26, respectively, that converted the Company's
variable rate debt into fixed obligations.

The weighted average interest rate for short-term debt outstanding was 6.4%,
5.2% and 5.1% for 2000, 1999 and 1998, respectively. At June 30, 2000 and 1999,
net of foreign currency swap agreements, the fair value of long-term debt was
$600 and $723, respectively, and the fair values of short-term debt approximate
the carrying value for those years.

The Company has credit agreements totaling up to $900 that expire on dates
through April 2002. There are no borrowings under any of these agreements. They
are available for general corporate purposes and for the support of additional
commercial paper issuance. The credit agreements require maintenance of minimum
net worth of $704.

Long-term debt maturities as of June 30, 2000 are $5, $207, $10, $216, $2 and
$155 in 2001, 2002, 2003, 2004, 2005 and thereafter, respectively.

10. DERIVATIVE INSTRUMENTS

The Company utilizes derivative instruments, principally swaps, forward
contracts and options to enhance its ability to manage risk, including interest
rate, foreign currency, commodity prices and share repurchases which exist as
part of its ongoing business operations. These contracts hedge transactions and
balances for periods consistent with the related exposures and do not constitute
investments independent of these exposures. The Company is not a party to any
leveraged contracts.

Interest rate swap agreements are used to manage interest rate exposure and to
achieve a desired proportion of variable and fixed rate debt. Amounts paid or
received on hedges related to debt are included in interest expense. At
June 30, 2000 and June 30, 1999, the notional amount of interest rate swaps was
$261 and $278, and the unrealized losses were approximately $11 and $4,
respectively. (See Note 9).

The Company uses foreign exchange contracts, including forward currency
contracts, a call option contract and swap contracts, to hedge existing
foreign-exchange exposures. Foreign currency contracts require the Company, at a
future date, either to buy or sell foreign currency in exchange for U.S. dollars
to offset an underlying exposure. Such currency contracts existed at June 30,
2000 and 1999 for Canadian dollars, Japanese yen, Australian dollars and certain
other currencies. The call option contract is for purchases

B-23

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

10. DERIVATIVE INSTRUMENTS (CONTINUED)
denominated in Deutsche marks. Foreign exchange contracts with notional amounts
totaling $262 and $67 were outstanding at June 30, 2000 and 1999, respectively.
Unrealized losses related to these contracts were approximately $2 at June 30,
1999 (none at June 30, 2000). Contracts outstanding as of June 30, 2000 will
mature over the next year. The Company manages its future Deutsche mark exposure
with foreign currency swap agreements (see Note 9). These agreements provide for
an exchange of notional amounts at a future date, enabling the Company to offset
future foreign currency cash exposures and converting Deutsche mark liability to
U.S. dollar liability, thus mitigating exposure to increasing costs associated
with foreign currency movements. The Company also holds Argentine foreign
currency contracts which are not accorded hedge accounting treatment. The
notional amounts on these contracts totaled $38 at June 30, 2000. Losses
recognized in 2000 on the Company's Argentine foreign currency contract were
insignificant.

The Company uses commodity futures contracts to hedge the price on a portion of
raw material purchases used in the manufacturing process and swap contracts to
hedge the market risk of diesel fuel included as part of carrier contracts.
Contract maturities are correlated to actual purchases and contract gains and
losses are reflected as adjustments of the cost of the related item. The Company
also uses swap contracts and an option contract with various maturities
partially to stabilize the cost of its polyethylene resin requirements. These
contracts cover a portion of the Company's domestic and foreign resin
requirements. Unrealized (gains) or losses on open contracts at June 30, 2000
and June 30, 1999 were approximately $(14) and $6, respectively.

Equity put options and forward contracts are used in connection with the
Company's common share repurchase programs (see Note 11).

The carrying values of cash, short-term investments, accounts and notes
receivable, notes payable, accounts payable, forward purchase financing
agreements and other derivative financial instruments approximate their fair
values at June 30, 2000 and 1999. The Company has used market information for
similar instruments and applied judgment in estimating fair values. See Note 9
for fair values of short-term and long-term debt.

Exposure to counterparty credit risk is considered low because these agreements
have been entered into with major credit worthy institutions with strong credit
ratings, and they are expected to perform fully under the terms of the
agreements.

11. STOCKHOLDERS' EQUITY

In addition to common stock, the Company is authorized to issue 5 million shares
of preferred stock with a par value of $1 per share, none of which is
outstanding.

In September 1999, in response to declines in the Company's stock price in the
first quarter, the Board of Directors authorized a common stock repurchase and
hedging program intended to reduce or eliminate dilution when shares are issued
in accordance with the Company's various stock compensation plans. The Company
had canceled a prior share repurchase and hedging program (previously authorized
in September 1996 by the Board of Directors to offset the dilutive effects of
employee stock exercises) when it merged with First Brands. The Company
repurchased a total of 3,123,000 shares for $135 from inception of the new
program through June 30, 2000 and, under the prior program, 800,000 shares for
$33 in 1999, and 1,694,000 shares for $83 in 1998.

B-24

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

11. STOCKHOLDERS' EQUITY (CONTINUED)

On September 15, 1999, the Company settled share repurchase agreements and
options contracts realizing net cash proceeds of approximately $76 million. On
the same day, the Company entered into two new share repurchase transactions
whereby the Company contracted for future delivery of 2,260,000 shares on
September 15, 2002 and 2,260,000 shares on September 15, 2004, each for a strike
price of $43 per share. In November 1999, the Company entered into an agreement
to purchase an additional 1,000,000 shares on December 1, 2003 at a price of
$46.32 per share.

12. STOCK COMPENSATION PLANS

At June 30, 2000, the Company had stock-based compensation plans that include
the pre-merger plans of First Brands, including various stock option plans that
provide for the granting of stock options to officers, key employees and
directors. The 1996 Stock Incentive Plan ("1996 Plan") and the 1993 Directors'
Stock Option Plan are the only plans with stock option awards currently
available for grant; the 1996 Plan, the 1993 Directors' Stock Option Plan and
prior plans have shares exercisable at June 30, 2000. The Company is authorized
to grant options for up to 14 million common shares under the 1996 Plan, of
which 9 million have been granted. Options outstanding under the Company's plans
(except First Brands options which became exercisable upon the merger) have been
granted at prices which are either equal to or above the market value of the
stock on the date of grant, vest over a one to seven-year period, and expire no
later than ten years after the grant date.

The status of the Company's stock option plans at June 30 is summarized below:

NUMBER WEIGHTED AVERAGE
OF SHARES EXERCISE PRICE
-------------- ----------------
(IN THOUSANDS)

Outstanding at June 30, 1997.................... 14,226 $18
Granted......................................... 1,282 36
Exercised....................................... (2,630) 14
Cancelled....................................... (438) 25
------ ---
Outstanding at June 30, 1998.................... 12,440 21
Granted......................................... 4,590 60
Exercised....................................... (3,174) 20
Cancelled....................................... (216) 35
------ ---
Outstanding at June 30, 1999.................... 13,640 34
Granted......................................... 3,104 40
Exercised....................................... (1,381) 20
Cancelled....................................... (301) 44
------ ---
Outstanding at June 30, 2000.................... 15,062 $36
====== ===

Options exercisable at:
June 30, 2000................................... 7,687 $21
June 30, 1999................................... 7,618 19
June 30, 1998................................... 8,204 17

B-25

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

12. STOCK COMPENSATION PLANS (CONTINUED)
Had compensation expense for the Company's various stock-based compensation
plans been determined based upon fair values at the grant dates for awards under
those plans in accordance with SFAS No. 123, "Accounting for Stock-Based
Compensation," the Company's net earnings and earnings per share would have been
reduced to the following pro forma amounts. The pro forma effects of applying
SFAS No. 123 are not indicative of future amounts because this statement does
not apply to awards granted prior to 1996.

2000 1999 1998
-------- -------- --------

Earnings before cumulative effect of change in
accounting principle
As reported.......................................... $ 394 $ 246 $ 350
Pro forma............................................ 373 235 343

Earnings per share before cumulative effect of change
in accounting principle
Basic
As reported........................................ $1.67 $1.05 $1.49
Pro forma.......................................... 1.58 1.00 1.46
Diluted
As reported........................................ $1.64 $1.03 $1.46
Pro forma.......................................... 1.56 0.98 1.43

The weighted average fair value of each option granted during 2000, 1999 and
1998, estimated on the grant date using the Black-Scholes option pricing model,
was $12.43 per share, $13.16 per share and $8.83 per share, respectively. The
following assumptions were used to estimate the fair value of the 2000, 1999 and
1998 option grants:

COMBINED COMBINED CLOROX FIRST BRANDS
2000 1999 1998 1998
------------ ------------ ------------ ------------

Dividend yield....................... 1.8% 1.3% 2% 1.5%
Expected volatility.................. 36.5% 29.5% 21% 42.6%
Risk-free interest rate.............. 5.7% to 6.8% 4.4% to 5.7% 5.3% to 6.5% 5.5%
Expected life........................ 3 to 6 years 3 to 6 years 3 to 5 years 7.7 years

Summary information about the Company's stock options outstanding at June 30,
2000 is as follows (number of shares in thousands):

RANGE OF WEIGHTED AVERAGE
EXERCISE OUTSTANDING CONTRACTUAL WEIGHTED AVERAGE EXERCISABLE WEIGHTED AVERAGE
PRICE AT 6/30/00 PERIODS IN YEARS EXERCISE PRICE AT 6/30/00 EXERCISE PRICE
- --------------------- ----------- ---------------- ---------------- ----------- ----------------

$ 9 - $20 4,621 3.7 $16 4,621 $16
21 - 32 2,004 6.2 23 2,001 23
32 - 44 4,465 9.0 37 1,021 37
44 - 55 590 9.0 52 40 48
56 - 67 3,382 8.9 66 4 59
- --------------------- ------ --- --- ----- ---
$ 9 - $67 15,062 8.0 $36 7,687 $21
===================== ====== === === ===== ===

B-26

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

13. LEASES

The Company leases transportation equipment and various manufacturing,
warehousing and office facilities. Most leases are classified as operating
leases and will expire over the next 16 years. Future total minimum lease
payments are $59, and do not exceed $19 in any one year. Rental expense was $49
in 2000, $36 in 1999 and $40 in 1998.

Space not occupied by the Company in its headquarters building is let to other
tenants under operating leases expiring by 2008. Future minimum rentals to be
received total $4 and do not exceed $2 in any one year.

14. OTHER (INCOME) EXPENSE, NET

The major components are:

2000 1999 1998
-------- -------- --------

Amortization of intangibles.............................. $ 55 $ 61 $ 57
Equity in earnings of affiliates......................... (16) (21) (17)
Interest income.......................................... (10) (7) (5)
Royalty income........................................... (6) (7) (11)
Other, net............................................... 1 (2) (14)
---- ---- ----
Total.................................................... $ 24 $ 24 $ 10
==== ==== ====

15. INCOME TAXES

The provision for income taxes is:

2000 1999 1998
-------- -------- --------

Current
Federal............................................... $193 $175 $119
State................................................. 25 25 16
Foreign............................................... 25 13 19
---- ---- ----
Total current........................................... 243 213 154
---- ---- ----

Deferred
Federal............................................... (11) (26) 43
State................................................. - (2) 7
Foreign............................................... (4) (1) 2
---- ---- ----
Total deferred.......................................... (15) (29) 52
---- ---- ----
Total................................................... $228 $184 $206
==== ==== ====

The effective income tax rates were 36.7%, 42.8% and 37.1% in 2000, 1999 and
1998, respectively. The primary differences between the U.S. statutory rate of
35% and the effective tax rate in each year are due to state income taxes, net
of federal benefits, of 2.7%, 3% and 2.9%, in 2000, 1999 and 1998, respectively,
and merger-related and restructuring costs of 5.9% in 1999.

B-27

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

15. INCOME TAXES (CONTINUED)
Undistributed earnings of foreign subsidiaries that are considered to be
reinvested indefinitely totaled $163 at June 30, 2000.

The net deferred income tax assets (liabilities), both current and non-current
at June 30, result from the tax effects of the following temporary differences:

2000 1999
-------- --------

Amortization and depreciation............................... $(183) $(190)
Safe harbor lease agreements................................ (16) (18)
Unremitted foreign earnings................................. (37) (41)
Post employment benefits.................................... 29 36
Merger related and restructuring costs...................... 24 20
Income previously recorded for book purposes................ (19) (13)
Other....................................................... 3 (5)
----- -----
Deferred tax liabilities -- Net............................. $(199) $(211)
===== =====

16. EMPLOYEE BENEFIT PLANS

RETIREMENT INCOME PLANS

The Company has defined benefit pension plans for substantially all its domestic
employees and certain of its international subsidiaries. Benefits are based on
either employee years of service and compensation or a stated dollar amount per
year of service. The Company is the sole contributor to the plans in amounts
deemed necessary to provide benefits and to the extent deductible for federal
income tax purposes. Assets of the plans consist primarily of stocks and bonds.

The projected benefit obligation, accumulated benefit obligation and fair value
of plan assets for those pension plans with accumulated benefit obligations in
excess of plan assets were $35, $28 and $27, respectively, as of June 30, 2000
and $2, $1 and $0, respectively, as of June 30, 1999.

The $1 curtailment gain in 2000 relates to the closure of certain facilities
associated with the First Brands merger. The $7 cost of special termination
benefits in 1999 relates to termination benefits related to the First Brands
merger.

RETIREMENT HEALTH CARE

The Company provides certain health care benefits for employees who meet age,
participation and length of service requirements at retirement. The plans pay
stated percentages of covered expenses after annual deductibles have been met.
Benefits paid take into consideration payments by Medicare. The plans are
unfunded and the Company has the right to modify or terminate certain of these
plans.

The assumed health care cost trend rate used in measuring the accumulated
post-retirement benefit obligation ("APBO") was 9% for years 2000 and 2001.
These rates were assumed to gradually decrease to 6% for 2003 and remain at that
level for years thereafter. Changes in these rates can have a significant effect
on amounts reported. A one percentage point increase in the trend rates would
increase the June 30,

B-28

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

16. EMPLOYEE BENEFIT PLANS (CONTINUED)
2000 APBO by $8 and increase expense in 2000 by $2. The discount rate used to
determine the APBO was 8.25%.

Summarized information for the Company's retirement income and retirement health
care plans are as follows:

RETIREMENT
RETIREMENT INCOME PLANS HEALTH CARE
-------------------------- ----------------------
2000 1999 2000 1999
----------- ------------ -------- --------

Change in benefit obligations
Benefit obligation at beginning of year.......... $247 $267 $ 77 $ 73
Service cost..................................... 10 12 3 3
Interest cost.................................... 19 19 5 5
Plan amendments.................................. - (9) - -
Reduction in prior service cost due to
remeasurement.................................. 2 (1) - -
Actuarial (gain)/loss............................ (6) (21) (2) -
Benefits paid.................................... (20) (27) (4) (4)
Special termination benefits..................... - 7 - -
---- ---- ---- ----
Benefit obligation at end of year................ 252 247 79 77

Change in plan assets
Fair value of assets at beginning of year........ 324 307 - -
Actual return on plan assets..................... 23 36 - -
Employer contribution............................ - 8 4 4
Benefits paid.................................... (21) (27) (4) (4)
Effect of foreign currency changes............... - - - -
---- ---- ---- ----
Fair value of plan assets at end of year......... 326 324 - -
Funded (unfunded) status......................... 74 77 (79) (77)
Unrecognized transition obligation/(asset)....... - (2) 7 7
Unrecognized prior service cost.................. (9) (14) 2 2
Unrecognized (gain)/loss......................... (49) (54) (8) (7)
---- ---- ---- ----
Prepaid/(accrued) benefit cost................... $ 16 $ 7 $(78) $(75)
==== ==== ==== ====
Amount recognized in the balance sheets consists
of:
Prepaid benefit cost............................. $ 31 $ 25 $ - $ -
Accrued benefit liability........................ (15) (18) (78) (75)
Accumulated other comprehensive income........... - - - -
---- ---- ---- ----
Net amount recognized............................ $ 16 $ 7 $(78) $(75)
==== ==== ==== ====

2000 1999 2000 1999
----------- ------------ -------- --------

Weighted average assumptions as of June 30:
Discount rate.................................... 6% to 8.25% 6% to 7.75% 8.25% 7.75%
Rate of compensation increase.................... 3% to 8.25% 3% to 7% N/A N/A
Expected return on plan assets................... 7% to 9.5% 7% to 9.5% N/A N/A

B-29

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

16. EMPLOYEE BENEFIT PLANS (CONTINUED)

RETIREMENT RETIREMENT
INCOME PLANS HEALTH CARE
------------------------------ ------------------------------
2000 1999 1998 2000 1999 1998
-------- -------- -------- -------- -------- --------

Components of net periodic benefit cost
Service cost.......................................... $ 10 $ 12 $ 10 $ 3 $ 3 $ 3
Employee contributions................................ - - - - - -
Interest cost......................................... 19 19 18 5 5 5
Expected return on plan assets........................ (30) (26) (23) - - -
Amortization of unrecognized items
Transition obligation/(asset)....................... (2) (2) (2) 1 1 1
Prior service cost.................................. (1) - (1) - - -
Net (gain)/loss..................................... (3) 3 - (1) - (1)
---- ---- ---- --- --- ---
Total net periodic benefit cost (income).............. (7) 6 2 8 9 8
Termination benefits and curtailment (gains)/
losses.............................................. (1) 1 (1) - 1 -
Termination benefits related to First Brands merger... - 6 - - - -
---- ---- ---- --- --- ---
Total expense (income)................................ $ (8) $ 13 $ 1 $ 8 $10 $ 8
==== ==== ==== === === ===

The expenses of employee termination related to the First Brands merger were
charged to merger, restructuring and asset impairment costs. The Company has
defined contribution plans for most of its domestic employees not covered by
collective bargaining agreements. Cost is based on the Company's profitability
and on participants' deferrals. The aggregate cost of the defined contribution
plans was $16 in 2000, $21 in 1999 and $26 in 1998.

17. INDUSTRY SEGMENT INFORMATION

Information regarding the Company's operating segments is shown below. Each
segment is individually managed with separate operating results that are
reviewed regularly by the chief operating decision maker. The operating segments
include:

- U. S. Household Products and Canada: Includes cleaning, bleach and other
home care products, and water filtration products, and all products
marketed in Canada.

- U. S. Specialty Products: Includes charcoal, automotive care, cat litter,
insecticides, food products, professional products and the food storage
and disposal categories.

- International Operations: Includes operations outside the United States
and Canada.

- Corporate, Interest and Other: Includes certain non-allocated
administrative costs, goodwill amortization, interest income, interest
expense, merger-related costs, and other income and expense. Corporate
assets include cash, marketable securities, the Company's headquarters and
research and development facilities.

B-30

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

17. INDUSTRY SEGMENT INFORMATION (CONTINUED)
The following table represents operating segment information. Operating segment
information for years ending June 30, 1999 and June 30, 1998 has been restated
to reflect the Company's current organizational structure and management
responsibilities.

U.S. HOUSEHOLD U.S. CORPORATE
FISCAL PRODUCTS AND SPECIALTY INTEREST & TOTAL
YEAR CANADA PRODUCTS INTERNATIONAL OTHER COMPANY
-------- -------------- --------- ------------- ---------- --------

Net Sales............................... 2000 $1,629 $1,826 $ 628 - $4,083
1999 1,545 1,856 602 - 4,003
1998 1,489 1,796 613 - 3,898

Earnings before Tax..................... 2000 500 506 81 $(465) 622
1999 510 461 60 (601) 430
1998 454 431 101 (430) 556

Identifiable Assets..................... 2000 1,048 1,510 1,037 758 4,353
1999 1,322 1,220 922 668 4,132
1998 1,267 1,138 950 710 4,065

Capital Spending........................ 2000 49 52 21 36 158
1999 59 64 23 30 176
1998 36 99 29 26 190

Depreciation and Amortization........... 2000 48 69 36 48 201
1999 45 68 38 51 202
1998 46 61 37 38 182

Interest Expense........................ 2000 - - - 98 98
1999 - - - 97 97
1998 - - - 104 104

Sales to the Company's largest customer, Wal-Mart Stores, Inc. and its
affiliates, were 18%, 18% and 15% of consolidated net sales in 2000, 1999 and
1998, respectively.

18. COMMITMENTS AND CONTINGENT LIABILITIES

The Company has obligations to certain suppliers to purchase raw materials, at
various prices for estimated annual requirements for periods through
September 2010. Estimated purchase commitments based on estimated annual
requirements and current market prices are no greater than $6 in any year for
the next five years.

The Company is subject to various lawsuits and claims, which include contract
disputes, environmental issues, product liability, patent and trademark matters,
advertising and taxes. Although the results of litigation cannot be predicted
with certainty, it is the opinion of management, after consultation with
counsel, that the ultimate disposition of these matters, to the extent not
previously provided for, will not have a material adverse effect, individually
or in the aggregate, on the Company's consolidated financial statements taken as
a whole.

B-31

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE CLOROX COMPANY

(MILLIONS OF DOLLARS, EXCEPT SHARE AND PER-SHARE AMOUNTS)

19. EARNINGS PER SHARE

A reconciliation of the weighted average number of shares outstanding (in
thousands) used to calculate basic and diluted earnings per share is as follows:

2000 1999 1998
-------- -------- --------

Basic............................................ 236,108 235,364 234,666
Stock options and other.......................... 3,506 4,638 4,874
------- ------- -------
Diluted.......................................... 239,614 240,002 239,540
======= ======= =======

B-32

RESPONSIBILITY FOR CONSOLIDATED FINANCIAL STATEMENTS

The Company's management is responsible for the integrity and objectivity of the
above financial statements. In fulfilling this responsibility, management
maintains an effective system of internal accounting controls and supports a
comprehensive internal audit program.

The Board of Directors has an Audit Committee consisting of independent
directors. The Audit Committee meets regularly with management, internal
auditors and Deloitte & Touche LLP, independent auditors. Deloitte & Touche LLP
and the internal auditors have full authority to meet with the Audit Committee,
either with or without management representatives present.

Deloitte & Touche LLP have completed their audit of the accompanying
consolidated financial statements. Their report appears below.

INDEPENDENT AUDITORS' REPORT

The Stockholders and Board of Directors of The Clorox Company:

We have audited the accompanying consolidated balance sheets of The Clorox
Company and its subsidiaries (the "Company") as of June 30, 2000 and 1999, and
the related consolidated statements of earnings, stockholders' equity and cash
flows for the years ended June 30, 2000, 1999 and 1998. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits. The consolidated financial statements give retroactive effect to the
merger of the Company and First Brands Corporation, which has been accounted for
as a pooling of interests as described in Note 1 to the consolidated financial
statements. We did not audit the statements of earnings, stockholders' equity
and cash flows of First Brands Corporation for the year ended June 30, 1998,
which statements reflect total revenues of $1,203,670,000 and net income of
$45,408,000. These statements were audited by other auditors whose report (which
contains an explanatory paragraph as to the change in accounting principle
described in Note 1 to the consolidated financial statements) has been furnished
to us, and our opinion, insofar as it relates to the amounts included for First
Brands Corporation for 1998, is based solely on the report of such other
auditors.

We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits and the report of
the other auditors referred to above provide a reasonable basis for our opinion.

In our opinion, based on our audits and the report of the other auditors
referred to above, the accompanying consolidated financial statements present
fairly, in all material respects, the financial position of the Company at
June 30, 2000 and 1999, and the results of its operations and its cash flows for
the years ended June 30, 2000, 1999, and 1998 in conformity with accounting
principles generally accepted in the United States of America.

DELOITTE & TOUCHE LLP

Oakland, California
August 25, 2000

B-33

INDEPENDENT AUDITORS' REPORT

The Board of Directors and Stockholders
of First Brands Corporation:

We have audited the accompanying consolidated statements of income,
stockholders' equity, and cash flows of First Brands Corporation and
subsidiaries for the year ended June 30, 1998. These consolidated financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these consolidated financial
statements based on our audit.

We conducted our audit in accordance with generally accepted auditing standards.
Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the results of operations and the cash flows
of First Brands Corporation and subsidiaries for the year ended June 30, 1998,
in conformity with generally accepted accounting principles.

As discussed in Note 1 to the consolidated financial statements, the Company
changed its method of accounting for business process re-engineering costs
effective October 1, 1997.

/s/ KPMG LLP
KPMG LLP

New York, New York
August 6, 1998

B-34

QUARTERLY DATA
THE CLOROX COMPANY

1ST 2ND 3RD 4TH
QUARTER QUARTER QUARTER(2) QUARTER(2) YEAR
- ---------------------------------------------------------------------------------------------------------------------------------
IN MILLIONS, EXCEPT PER-SHARE AMOUNTS.

Year ended June 30, 2000
Net Sales........................... $ 942 $ 954 $ 1,034 $ 1,153 $ 4,083
Cost of Products Sold............... 517 535 573 625 2,250
Net Earnings........................ 87 76 106 125 394

Per Common Share (1)
Net Earnings
Basic............................. $ 0.37 $ 0.32 $ 0.45 $ 0.53 $ 1.67
Diluted........................... 0.36 0.32 0.44 0.52 1.64
Dividends........................... 0.20 0.20 0.20 0.20 0.80
Market Price (NYSE)
High.............................. 58 1/4 56 56 3/8 47 58 1/4
Low............................... 37 9/16 37 1/2 29 1/16 32 3/8 29 1/16
Year-end.......................... 44 13/16

Year ended June 30, 1999
Net Sales........................... $ 964 $ 947 $ 992 $ 1,100 $ 4,003
Cost of Products Sold(3)............ 519 517 533 612 2,181
Net Earnings........................ 100 74 22 50 246

Per Common Share(1)
Net Earnings
Basic............................. $ 0.42 $ 0.32 $ 0.09 $ 0.21 $ 1.05
Diluted........................... 0.42 0.31 0.09 0.21 1.03
Dividends........................... 0.17 0.18 0.18 0.18 0.71
Market Price (NYSE)
High.............................. 55 15/16 58 11/16 66 15/32 62 7/8 66 15/32
Low............................... 39 11/16 40 53 29/32 46 1/4 39 11/16
Year-end.......................... 53 13/32

- ---------

(1) Due to rounding, EPS for the year may not equal the sum of the quarterly
EPS.

(2) Net earnings for the fourth quarter of 2000 include Asia restructuring
costs. Net earnings for the third and fourth quarters of 1999 include the
effect of significant merger, restructuring, and asset impairment costs.

(3) Delivery costs, previously reported as part of selling, delivery and
administration, are now included in cost of products sold. Selling, delivery
and administration expense and cost of products sold for prior periods have
been restated to conform to the current presentation.

B-35

FIVE-YEAR FINANCIAL SUMMARY
THE CLOROX COMPANY

YEARS ENDED JUNE 30 2000 1999 1998 1997 1996
- ------------------------------------------------------------------------------------------------
IN MILLIONS, EXCEPT SHARE AND PER-SHARE DATA.

OPERATIONS
Net sales.................................... $ 4,083 $ 4,003 $ 3,898 $ 3,623 $ 3,265
------- ------- ------- ------- -------
Percent change............................... 2.0 2.7 7.6 11.0 9.0
------- ------- ------- ------- -------
Cost of products sold(1)..................... 2,250 2,181 2,124 1,976 1,817
Operating expenses(1)........................ 1,053 1,091 1,101 1,045 893
Other........................................ 122 121 114 84 76
Merger, restructuring and asset impairment... 36 180 3 19 -
------- ------- ------- ------- -------
Total costs and expenses..................... 3,461 3,573 3,342 3,124 2,786
------- ------- ------- ------- -------
Earnings before income taxes and cumulative
effect of change in accounting principle... 622 430 556 499 479
Income taxes................................. 228 184 206 199 192
------- ------- ------- ------- -------
Earnings before cumulative effect of change
in accounting principle.................... 394 246 350 300 287
Cumulative effect of change in accounting
principle.................................. - - (7) - -
------- ------- ------- ------- -------
Net earnings................................. $ 394 $ 246 $ 343 $ 300 $ 287
======= ======= ======= ======= =======
Percent change................................. 60.2 (28.3) 14.3 4.5 19.6

COMMON STOCK

Weighted average shares outstanding (in
thousands)
Basic...................................... 236,108 235,364 234,666 235,042 236,818
Diluted.................................... 239,614 240,002 239,540 239,346 239,746
Net earnings per common share
Basic...................................... $ 1.67 $ 1.05 $ 1.46 $ 1.27 $ 1.21
Diluted.................................... 1.64 1.03 1.43 1.25 1.20
Dividends per common share................... 0.80 0.71 0.63 0.56 0.51
Stockholders' equity per common share at end
of year.................................... 7.62 6.67 6.32 6.10 5.74

OTHER DATA
Property, plant and equipment -- Net......... 1,079 1,054 1,016 948 871
Property additions........................... 158 176 190 161 137
Long-term debt............................... 590 702 704 946 556
Percent return on net sales.................. 9.6 6.1 8.8 8.3 8.8
Total assets................................. 4,353 4,132 4,065 3,799 3,017
Stockholders' equity......................... 1,794 1,570 1,473 1,430 1,349
Percent return on average stockholders'
equity..................................... 23.4 16.1 23.9 21.7 21.9

- ---------

(1) Delivery costs, previously included above in operating expense, are now
included in cost of products sold. Prior period amounts have been
reclassified to conform to the current period presentation.

B-36

P R O X Y

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF THE CLOROX
COMPANY

The undersigned, whose signature appears on the reverse, hereby
appoints G. C. SULLIVAN, P. D. BEWLEY and K. M. ROSE, and each of them,
proxies with full power of substitution for and in the name of the
undersigned to vote all the shares of Common Stock of The Clorox Company
which the undersigned would be entitled to vote if personally present at the
Annual Meeting of Stockholders to be held on November 15, 2000, and at any
and all adjournments thereof, on all matters that may properly come before
the meeting.

Your shares will be voted as directed on this card. If signed and no
direction is given for any item, it will be voted in favor of Items 1 and 2.

To vote by telephone or Internet, please see the reverse of this card. To
vote by mail, please sign and date this card on the reverse, tear off at the
perforation, and mail promptly in the enclosed postage-paid envelope.

If you have any comments or a change of address, MARK THE APPROPRIATE BOX ON
THE REVERSE SIDE and use the following space:

- ----------------------------------------------------------------------------

- ----------------------------------------------------------------------------
YOUR VOTE IS IMPORTANT. BY RETURNING YOUR VOTING INSTRUCTIONS PROMPTLY, YOU
CAN AVOID THE INCONVENIENCE OF RECEIVING FOLLOW-UP MAILINGS PLUS HELP THE
COMPANY AVOID ADDITIONAL EXPENSES.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
DETACH PROXY CARD HERE IF YOU ARE VOTING BY MAIL AND RETURN IN ENCLOSED ENVELOPE

CLOROX HAS EXPANDED THE SERVICES AVAILABLE ON OUR SHAREHOLDER DIRECT LINE.

Call 1-888-CLX-NYSE (1-888-259-6973) to access our expanded Clorox
Shareholder Direct Services. Use the menu below to navigate through the
options available to you:

Press 1 Delayed Stock Quote
Press 2 Dividend/Earnings Information
Press 3 News Releases
Press 4 Printed Materials Requests
Press 1 to request faxed press releases
Press 2 to request a mailed copy of available printed
materials
Press 5 Shareholder Services
Press 1 to reach our transfer agent
Press 2 to reach Clorox Investor Relations
Press 6 Frequently Asked Questions

Log onto our web site at www.clorox.com/investors to view many of these same
items online or to request mailed materials. You can even sign up for our
news by email service.

[CLOROX LOGO]

/x/ PLEASE MARK CHOICES IN BLUE OR BLACK INK AS IN THIS SAMPLE. 0129

The Board of Directors unanimously recommends a vote FOR the election of the
nominees for director and FOR proposal 2.

NOMINEES
- --------

01 Daniel Boggan, Jr. 05 Juergen Manchot 09 Lary R. Scott
02 Elaine L. Chao 06 Robert W. Matschullat 10 G. Craig Sullivan
03 Tully M. Friedman 07 Dean O. Morton 11 C. A. (Al) Wolfe
04 Christoph Henkel 08 Klaus Morwind

FOR WITHHELD
1. Election of Directors / / / /
(See list to the left.)

For, except vote withheld from the following nominee(s):

- --------------------------------------------------------

FOR AGAINST ABSTAIN
2. Proposal to ratify the selection / / / / / /
of Deloitte & Touche LLP, certified
public accountants, for the fiscal
year ending June 30, 2001.

Check this box if you have comments / /
or a change of address and use the back
of this card.

Check this box if you wish to attend and / /
vote at the meeting.

SIGNATURE(S) DATE
------------------------------------------------ --------------

NOTE: Your signature should conform with your name as printed above. If
signing as attorney, executor, administrator, trustee or guardian, please
give your full title. If stock is owned by a partnership or corporation,
please indicate your capacity in signing the proxy. If stock is held in joint
partnership, all co-owners must sign. Please sign, date and return
promptly.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
DETACH PROXY CARD HERE IF YOU ARE VOTING BY MAIL AND RETURN IN ENCLOSED
ENVELOPE

THE CLOROX COMPANY - ANNUAL MEETING - NOVEMBER 15, 2000

CLOROX OFFERS PHONE OR INTERNET VOTING
24 hours a day, 7 days a week

ON A TOUCH-TONE PHONE, CALL TOLL-FREE 1-877-779-8683 (OUTSIDE THE UNITED
STATES, CANADA, PUERTO RICO AND THE U.S. VIRGIN ISLANDS, CALL 201-536-8073).
YOU WILL BE PROMPTED FOR THE FOLLOWING:

- - Enter the last four digits from your Social Security number.

- - Enter the control number from the box above, just below the
perforation.

- - You will then have two options:

OPTION 1: To vote as the Board of Directors recommends on both
proposals; or

OPTION 2: To vote on each proposal separately.

- - Your vote will be repeated to you and you will be asked to confirm it.

LOG ONTO THE INTERNET AND TYPE: WWW.EPROXYVOTE.COM/CLX

- - Have your proxy card ready and follow the instructions.

- - You will be able to elect to receive future mailings via the Internet.

Your electronic vote authorizes the proxies named on the reverse of this card
to vote your shares to the same extent as if you marked, signed, dated and
returned the proxy card.

IF YOU HAVE VOTED BY PHONE OR INTERNET, PLEASE DO NOT RETURN THE PROXY CARD.

THANK YOU FOR VOTING!

[CLOROX LOGO]